Trulieve Cannabis (TCNNF) 10-Q 9 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 03, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	000-56248
Entity Registrant Name	TRULIEVE CANNABIS CORP.
Entity Incorporation, State or Country Code	A1
Entity Tax Identification Number	84-2231905
Entity Address, Address Line One	6749 Ben Bostic Road
Entity Address, City or Town	Quincy
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32351
City Area Code	850
Local Phone Number	298-8866
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001754195
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Subordinate Voting Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		159,761,126
Multiple Voting Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		26,226,386

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023		Dec. 31, 2022
Current Assets:
Cash and Cash Equivalents, at Carrying Value	$ 192,159	[1]	$ 207,185	[2]
Restricted cash	6,711		6,607
Accounts receivable, net	6,886		6,507
Inventories	229,897		276,505
Prepaid expenses and other current assets	43,733		62,278
Notes receivable - current portion	1,069		728
Assets associated with discontinued operations	6,214		33,733
Total current assets	486,669		593,543
Property and equipment, net	687,578		743,260
Right of use assets - operating, net	96,251		98,926
Right of use assets - finance, net	61,092		70,495
Intangible assets, net	934,560		984,797
Goodwill	483,905		791,495
Notes receivable, net	12,039		11,992
Other assets	11,087		12,768
Long-term assets associated with discontinued operations	2,010		93,129
TOTAL ASSETS	2,775,191		3,400,405
Current Liabilities:
Accounts payable and accrued liabilities	86,443		82,023
Income tax payable	0		49,615
Deferred revenue	3,561		9,459
Notes payable - current portion	9,117		12,453
Private placement notes - current portion, net	126,908		0
Operating lease liabilities - current portion	9,697		10,291
Finance lease liabilities - current portion	7,537		8,271
Construction finance liabilities - current portion	1,393		1,189
Contingencies	3,848		34,666
Liabilities associated with discontinued operations	3,268		2,328
Total current liabilities	251,772		210,295
Long-term liabilities:
Notes payable, net	92,309		94,247
Private placement notes, net	362,829		541,664
Operating lease liabilities	92,611		99,851
Finance lease liabilities	63,642		69,948
Construction finance liabilities	136,823		137,144
Deferred tax liabilities	205,441		224,903
Other long-term liabilities	86,439		26,279
Long-term liabilities associated with discontinued operations	42,616		68,370
TOTAL LIABILITIES	1,334,482		1,472,701
Commitments and contingencies
SHAREHOLDERS' EQUITY
Common stock, no par value; unlimited shares authorized. 185,987,512 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.	0		0
Additional paid-in-capital	2,052,418		2,045,003
Accumulated deficit	(607,208)		(113,843)
Non-controlling interest	(4,501)		(3,456)
TOTAL SHAREHOLDERS' EQUITY	1,440,709		1,927,704
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 2,775,191		$ 3,400,405
Common stock, shares authorized, unlimited (in shares) [Fixed List]	Unlimited		Unlimited
[1]Excludes $0.1 million attributable to discontinued operations.[2] Excludes $5.7 million attributable to discontinued operations.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common stock, no par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized, unlimited (in shares) [Fixed List]	Unlimited	Unlimited
Common stock, shares issued (in shares)	185,987,512	185,987,512
Common stock, shares outstanding (in shares)	185,987,512	185,987,512

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 275,210	$ 295,353	$ 842,219	$ 919,753
Cost of goods sold	132,264	126,641	407,444	387,736
Gross profit	142,946	168,712	434,775	532,017
Expenses:
Sales and marketing	59,398	74,327	181,206	219,680
General and administrative	34,455	37,613	108,669	104,602
Depreciation and amortization	26,958	29,471	82,624	86,621
Impairments and disposals of long-lived assets, net	(1,209)	54,639	5,480	76,155
Impairment of goodwill	0	0	307,590	0
Total expenses	119,602	196,050	685,569	487,058
Income (loss) from operations	23,344	(27,338)	(250,794)	44,959
Other (expense) income:
Interest expense, net	(20,834)	(17,731)	(60,925)	(52,229)
Change in fair value of derivative liabilities - warrants	0	365	252	2,627
Other income, net	11,214	448	18,108	3,016
Total other expense, net	(9,620)	(16,918)	(42,565)	(46,586)
Income (loss) before provision for income taxes	13,724	(44,256)	(293,359)	(1,627)
Provision for income taxes	36,640	28,370	105,933	116,770
Net loss from continuing operations	(22,916)	(72,626)	(399,292)	(118,397)
Net loss from discontinued operations, net of tax (provision) benefit of $5, $13,152, $(625), and $14,467, respectively	(2,927)	(42,446)	(99,054)	(53,178)
Net loss	(25,843)	(115,072)	(498,346)	(171,575)
Less: Net loss attributable to non-controlling interest from continuing operations	(451)	(518)	(3,788)	(2,555)
Less: Net loss attributable to non-controlling interest from discontinued operations	0	0	(1,193)	0
Net loss attributable to common shareholders	$ (25,392)	$ (114,554)	$ (493,365)	$ (169,020)
Net loss per share - Continuing operations:
Basic (in dollars per share)	$ (0.12)	$ (0.38)	$ (2.09)	$ (0.63)
Diluted (in dollars per share)	(0.12)	(0.38)	(2.09)	(0.63)
Net loss per share - Discontinued operations:
Basic (in dollars per share)	(0.02)	(0.23)	(0.52)	(0.28)
Diluted (in dollars per share)	$ (0.02)	$ (0.23)	$ (0.52)	$ (0.28)
Weighted average number of common shares used in computing net loss per share:
Basic (in shares)	188,924,694	188,597,094	188,959,454	187,549,359
Diluted (in shares)	188,924,694	188,597,094	188,959,454	187,549,359

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net (income) loss from discontinued operations, net of tax (provision)	$ 5	$ 13,152	$ (625)	$ 14,467

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Multiple Voting Shares	Subordinate Voting Shares	Subordinate Voting Shares PurePenn, Pioneer, Solevo	Common Shares	Common Shares PurePenn, Pioneer, Solevo	Additional Paid-in-Capital	Accumulated (Deficit) Earnings	Non-Controlling Interest
Beginning Balance (in shares) at Dec. 31, 2021		51,916,999	128,587,173		180,504,172
Beginning balance at Dec. 31, 2021	$ 2,147,373						$ 2,008,100	$ 137,721	$ 1,552
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	4,564						4,564
Exercise of stock options (in shares)			45,775		45,775
Exercise of stock options	108						108
Shares issued for cash - warrant exercise (in shares)			1,648		1,648
Shares issued for cash - warrant exercise	22						22
Shares issued under share compensation plans (in shares)			16,257		16,257
Tax withholding related to net share settlement of equity awards (in shares)			(10,005)		(10,005)
Tax withholding related to net share settlements of equity awards	(230)						(230)
Conversion of Multiple Voting to Subordinate Voting Shares (in shares)		(2,699,100)	2,699,100
Shares issued for PurePenn, Pioneer, and Solevo earnouts (in shares)				3,626,295		3,626,295
Distribution	(50)								(50)
Divestment of variable interest entity	(111)								(111)
Net loss	(32,482)							(31,975)	(507)
Ending Balance (in shares) at Mar. 31, 2022		49,217,899	134,966,243		184,184,142
Ending balance at Mar. 31, 2022	2,119,194						2,012,564	105,746	884
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	5,703						5,703
Exercise of stock options (in shares)			2,997		2,997
Shares issued for cash - warrant exercise (in shares)			1,426,614		1,426,614
Shares issued for cash - warrant exercise	19,216						19,216
Subordinate Voting Shares issued under share compensation plans (in shares)			24,444		24,444
Conversion of Multiple Voting to Subordinate Voting Shares (in shares)		(13,091,800)	13,091,800
Net loss	(24,021)							(22,491)	(1,530)
Ending Balance (in shares) at Jun. 30, 2022		36,126,099	149,512,098		185,638,197
Ending balance at Jun. 30, 2022	2,120,092						2,037,483	83,255	(646)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	4,292						4,292
Exercise of stock options (in shares)			5,655		5,655
Exercise of stock options	48						48
Tax withholding related to net share settlement of equity awards (in shares)			(399)		(399)
Tax withholding related to net share settlements of equity awards	(75)						(75)
Conversion of Multiple Voting to Subordinate Voting Shares (in shares)		(9,891,045)	9,891,045
Release of escrow shares (in shares)			236,756		236,756
Measurement period adjustment for Harvest Health and Recreation, Inc.	1,595								1,595
Net loss	(115,072)							(114,554)	(518)
Ending Balance (in shares) at Sep. 30, 2022		26,235,054	159,645,155		185,880,209
Ending balance at Sep. 30, 2022	2,010,880						2,041,748	(31,299)	431
Beginning Balance (in shares) at Dec. 31, 2022		26,226,386	159,761,126		185,987,512
Beginning balance at Dec. 31, 2022	1,927,704						2,045,003	(113,843)	(3,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	2,401						2,401
Distribution	(50)								(50)
Value of shares earned for purchase of variable interest entity	1,643						1,643
Net loss	(65,631)							(64,124)	(1,507)
Ending Balance (in shares) at Mar. 31, 2023		26,226,386	159,761,126		185,987,512
Ending balance at Mar. 31, 2023	1,866,067						2,049,047	(177,967)	(5,013)
Beginning Balance (in shares) at Dec. 31, 2022		26,226,386	159,761,126		185,987,512
Beginning balance at Dec. 31, 2022	$ 1,927,704						2,045,003	(113,843)	(3,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	0
Ending Balance (in shares) at Sep. 30, 2023		26,226,386	159,761,126		185,987,512
Ending balance at Sep. 30, 2023	$ 1,440,709						2,052,418	(607,208)	(4,501)
Beginning Balance (in shares) at Mar. 31, 2023		26,226,386	159,761,126		185,987,512
Beginning balance at Mar. 31, 2023	1,866,067						2,049,047	(177,967)	(5,013)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	475						475
Termination of purchase of variable interest entity	(1,643)						(1,643)
Deconsolidation and divestment of variable interest entities	3,986								3,986
Net loss	(406,872)							(403,849)	(3,023)
Ending Balance (in shares) at Jun. 30, 2023		26,226,386	159,761,126		185,987,512
Ending balance at Jun. 30, 2023	1,462,013						2,047,879	(581,816)	(4,050)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	4,539						4,539
Net loss	(25,843)							(25,392)	(451)
Ending Balance (in shares) at Sep. 30, 2023		26,226,386	159,761,126		185,987,512
Ending balance at Sep. 30, 2023	$ 1,440,709						$ 2,052,418	$ (607,208)	$ (4,501)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023		Sep. 30, 2022
Cash flow from operating activities
Net loss	$ (498,346)		$ (171,575)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	83,618		91,049
Depreciation included in cost of goods sold	45,397		39,119
Non-cash interest expense, net	4,233		3,615
Gain on extinguishment of debt	(8,161)		0
Impairments and disposals of long-lived assets, net	5,480		76,155
Impairment of goodwill	307,590		0
Amortization of operating lease right of use assets	7,794		8,443
Accretion of construction finance liabilities	1,050		1,044
Share-based compensation	7,415		14,559
Change in fair value of derivative liabilities - warrants	(252)		(2,627)
Non-cash change in contingencies	(1,334)		16,609
Allowance for credit losses	866		2,362
Deferred income tax expense	(18,696)		(34,855)
Loss from disposal of discontinued operations	69,840		49,069
Changes in operating assets and liabilities:
Inventories	66,527		(87,173)
Accounts receivable	(1,856)		(5,150)
Prepaid expenses and other current assets	9,286		5,773
Other assets	2,047		(4,397)
Accounts payable and accrued liabilities	4,519		1,839
Income tax payable	(49,869)		(24,615)
Other current liabilities	(13,058)		(4,035)
Operating lease liabilities	(6,933)		(7,205)
Deferred revenue	(6,005)		(782)
Other long-term liabilities	59,225		865
Net cash provided by (used in) operating activities	70,377		(31,913)
Cash flow from investing activities
Purchases of property and equipment	(30,998)		(130,422)
Purchases of property and equipment related to construction finance liabilities	0		(13,247)
Capitalized interest	114		(3,994)
Acquisitions and divestments, net of cash	977		(26,177)
Purchases of internal use software	(7,741)		(7,281)
Cash paid for licenses	(3,971)		(1,855)
Proceeds from sale of long-lived assets	4,918		502
Proceeds from sale of held for sale assets	5,828		2,173
Proceeds received from notes receivable	565		1,298
Net cash used in investing activities	(30,308)		(179,003)
Cash flow from financing activities
Proceeds from debt financings, net of discounts	0		76,715
Proceeds from construction finance liabilities	0		7,047
Proceeds from equity exercises	0		19,394
Payments on notes payable	(5,521)		(2,687)
Payments on private placement notes	(47,595)		(1,874)
Payments on finance lease obligations	(5,720)		(5,215)
Payments on construction finance liabilities	(1,285)		(891)
Payments for debt extinguishment and issuance costs	(428)		(189)
Payments for taxes related to net share settlement of equity awards	0		(305)
Distributions	(50)		(50)
Net cash (used in) provided by financing activities	(60,599)		91,945
Net decrease in cash and cash equivalents	(20,530)		(118,971)
Cash, cash equivalents, and restricted cash, beginning of period	213,792		229,644
Cash and cash equivalents of discontinued operations, beginning of period	5,702		4,015
Less: cash and cash equivalents of discontinued operations, end of period	(94)		(14,033)
Cash, cash equivalents, and restricted cash, end of period	198,870		100,655
Supplemental disclosure of cash flow information
Interest	52,036		42,339
Income taxes, net of refunds	113,187		161,717
Other noncash investing and financing activities
ASC 842 lease additions - operating and finance leases	12,019		28,352
Purchases of property and equipment in accounts payable and accrued liabilities	4,284		7,266
Noncash partial extinguishment of construction finance liability	18,486		0
Reclassification of assets to held for sale	18,396		4,558
Acquisition fair value adjustments	0		1,595
Cash and cash equivalents, beginning balance	207,185	[1]	226,631	[2]
Restricted cash, beginning balance	6,607		3,013
Cash and cash equivalents, ending balance	192,159	[3]	100,655	[4]
Restricted cash, ending balance	$ 6,711		$ 0
[1] Excludes $5.7 million attributable to discontinued operations. Excludes $4.0 million attributable to discontinued operations.

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Statement of Cash Flows [Abstract]
Cash and cash equivalents, attributable to discontinued operations	$ 0.1	$ 4	$ 14	$ 5.7

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of Trulieve Cannabis Corp., ("Trulieve" and, together with its subsidiaries and variable interest entities, the "Company," "our," or "us") has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and, therefore, do not include all financial information and footnotes required by GAAP for complete financial statements. In management's opinion, the condensed consolidated financial statements include all adjustments of a normal recurring nature necessary to fairly present the Company's financial position as of September 30, 2023, and the results of its operations and cash flows for the periods ended September 30, 2023 and 2022. The results of the Company's operations for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full 2023 fiscal year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for Trulieve Cannabis Corp. and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission ("SEC") on March 8, 2023 (the "2022 Form 10-K"). Discontinued Operations In June 2023, the Company determined to exit our operations in Massachusetts which represented a strategic shift in the business. The related assets and liabilities associated with the Company's discontinued operations are classified as discontinued operations on the condensed consolidated balance sheets and the results of our discontinued operations have been presented as discontinued operations within the condensed consolidated statements of operations for all periods presented. Unless specifically noted otherwise, footnote disclosures reflect the results of continuing operations only. In September 2022, the Company's exit of Nevada was deemed discontinued operations. The results of discontinued operations are presented in Note 16. Discontinued Operations . Reclassifications

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The Company’s significant accounting policies are more fully described in Note 3. Summary of Significant Accounting Policies in the consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022. There have been no material changes to the Company’s significant accounting policies. Fair Value of Financial Instruments The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices in active markets, which are observable for the asset or liability, either directly or indirectly; and Level 3 – Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions. The fair values of financial instruments by class are as follows as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (in thousands) Financial Assets: Money market funds (1) $ 164,405 $ — $ — $ 164,405 $ 340 $ — $ — $ 340 Financial Liabilities: Interest rate swap (2) $ — $ 365 $ — $ 365 $ — $ 2,536 $ — $ 2,536 Warrant liabilities (3) $ — $ — $ — $ — $ — $ 252 $ — $ 252 There have been no transfers between hierarchy levels during the periods ending September 30, 2023 or December 31, 2022. (1) Money market funds are included within cash and cash equivalents and restricted cash in the Company’s condensed consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that approximate fair value. The Company recorded interest income of $1.6 million and $3.4 million during the three and nine months ended September 30, 2023 in relation to money market funds. Interest income for the three and nine months ended September 30, 2022 was nominal. Interest income is recorded to other income net, on the condensed consolidated statements of operations. (2) The fair value of the interest rate swap liability is recorded in other long-term liabilities on the condensed consolidated balance sheets. In November 2022 the Company entered into an interest rate swap contract ("VNB Swap") for the purpose of hedging the variability of interest expense and interest payments on the Company's long-term variable debt. The VNB Swap is carried at fair value which is based on a valuation model that utilizes interest rate yield curves and credit spreads observable in active markets as the significant inputs to the model. The Company considers credit risk associated with its own standing as well as the credit standing of any counterparties involved in the valuation of its financial instruments. (3) The total fair value and carrying value of the Company's liability warrants is recorded to warrant liabilities on the condensed consolidated balance sheets. All remaining liability warrants expired during the three months ended June 30, 2023. Deferred Revenue During the three months ended March 31, 2023, the Company terminated the loyalty program associated with dispensaries acquired with the October 2021 acquisition of Harvest Health & Recreation, Inc. ("Harvest") . As a result of the termination of the loyalty program at certain dispensaries, the Company recorded a reduction in the accrual of $4.7 million in revenue in the condensed consolidated statements of operations. As of September 30, 2023 and December 31, 2022, the loyalty liability totaled $3.0 million and $8.9 million, respectively, and is included in deferred revenue on the condensed consolidated balance sheets. Included within deferred revenue as of September 30, 2023 and December 31, 2022 are customer credit balances of $0.6 million and $0.5 million, respectively. Impairment of Long-Lived Assets The Company reviews long-lived assets, including property and equipment, definite life intangible assets, and right-of-use assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. During the three months ended March 31, 2023, the Company determined that certain long-lived assets, including intangible assets, in Massachusetts were impaired due to the competitive environment in the Massachusetts cannabis industry. The Company utilized a cost approach for its impairment testing of property and equipment resulting in an impairment of $30.3 million, of which $27.6 million relates to discontinued operations and recorded to net loss from discontinued operations, net of tax benefit, and $2.7 million relates to continuing operations recorded in impairment and disposal of long-lived assets, net in the condensed consolidated statements of operations, respectively. During the three months ended September 30, 2023, the Company did not identify any events or changes in circumstances providing indication of impairment. Impairment of Goodwill The Company operates as one operating segment and reporting unit and therefore, evaluates goodwill for impairment as one singular reporting unit annually during the fourth quarter or more often when an event occurs, or circumstances indicate the carrying value may not be recoverable. The determination of the fair value of the reporting unit requires us to make significant estimates and assumptions. Due to the inherent uncertainty involved in making these estimates, actual future results could differ. Changes in assumptions regarding future results or other underlying assumptions could have a significant impact on the fair value of the reporting unit. The discounted cash flow model, or the income approach, reflects our estimates of future cash flows and other factors including estimates of future operating performance, including future revenue, long-term growth rates, gross margins, capital expenditures, discount rates and the probability of achieving the estimated cash flows, among others. In addition to the income approach, the Company also employs the market approach in its goodwill impairment testing. Under the market approach, the Company estimates the fair value based upon multiples of comparable public companies. Significant estimates in the market approach include identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, as well as assessing comparable market multiples in estimating the fair value of the reporting unit. During the three months ending March 31, 2023, the Company continued to experience a decline in its stock price resulting in the total market value of its common stock outstanding ("market capitalization") being less than the carrying value of the reporting unit. Management believes this decline in market value is due to a variety of factors, as further described below. In light of the circumstances and indicators of potential impairment described above, management performed an interim quantitative goodwill impairment test as of March 31, 2023. Management first considered whether any impairment was present for the Company’s long-lived assets, concluding that no such impairments were present after conducting an undiscounted cash flow recoverability test, except for in the Massachusetts market as detailed above. In comparing the estimated fair value of the reporting unit to its carrying value, the Company utilized a weighted average valuation using the discounted cash flow model and the market approach. The results of the Company’s interim test for impairment as of March 31, 2023 concluded that the estimated fair value of the reporting unit exceeded the carrying value, resulting in no impairment. During the three months ended June 30, 2023, the Company continued to experience a declined stock price resulting in the market capitalization being less than the carrying value of the reporting unit. The Company updated the March 31, 2023 valuation, as of June 30, 2023, with no impairment identified finding all inputs, including but not limited to future operating performance, gross margins, probability of achieving cash flows, and multiples of comparable public companies, either maintained consistency or trended positively for the three months ended June 30, 2023. Furthermore, the Company performed a sensitivity test on the income approach updating for the exit of the Massachusetts operations identifying the Massachusetts exit accretive to earnings as the Massachusetts assets were underperforming. However, the Company concluded the sustained stock price decline was a triggering event to perform an interim quantitative goodwill impairment test, as of June 30, 2023, specific to the stock price decline and resulting market capitalization of the Company. As the sole risk to the value of goodwill was the stock price, the Company concluded it most appropriate to transition to a market approach. The results of the Company’s interim test for impairment as of June 30, 2023, utilizing a market approach, indicated that the reporting unit's fair value fell below the carrying value. Based on the results of the goodwill impairment procedures, the Company recorded a $307.6 million goodwill impairment for the single reporting unit during the three months ended June 30, 2023. The Company found the June 30, 2023 goodwill impairment to be a result of the cannabis equity market including the reduced number of custodians to service cannabis equity holdings, negative investor sentiment due to lack of progress on federal reform, and more challenging macroeconomic conditions driving lower cannabis stock prices as of June 30, 2023. The Company finds this is not a negative indicator of historic or current operating results and not a negative indicator of anticipated future performance as the Company has taken steps to shed underperforming assets while focusing on cash conservation which is reflective in the results of operations as of June 30, 2023. Additionally, the resulting non-cash charge has no impact on the Company’s compliance with debt covenants, its cash flows, or available liquidity. As of September 30, 2023, the Company did not identify any events or changes in circumstances providing indication of impairment.

Accounts Receivable

Accounts Receivable	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Accounts Receivable	ACCOUNTS RECEIVABLE Accounts receivable consisted of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Trade receivables $ 9,979 $ 8,482 Less: allowance for credit losses (3,093) (1,975) Accounts receivable, net $ 6,886 $ 6,507

Notes Receivable

Notes Receivable	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Notes Receivable	NOTES RECEIVABLE Notes receivable consisted of the following as of September 30, 2023 and December 31, 2022: September 30, December 31, Stated Interest Rate Maturity Date (in thousands) Promissory note acquired in October 2021 (1) $ 7,665 $ 8,205 7.50 % 11/9/2025 Promissory note dated November 15, 2021 (2) 4,949 4,602 9.75 % 11/14/2024 Promissory note dated July 11, 2023 (1) 550 — 10.00 % 7/14/2025 Notes receivable 13,164 12,807 Less: discount on notes receivable (56) (87) Total notes receivable, net of discount 13,108 12,720 Less: current portion of notes receivable (1,069) (728) Notes receivable, net $ 12,039 $ 11,992 (1) Interest and principal payments are due to the Company monthly. (2) No payments are due to the Company until maturity. Interest is accrued monthly and added to the principal balance at each quarter end. The note is convertible to equity of the holder at the Company's option at any time prior to maturity. The note was issued with a nominal discount, resulting in an effective interest rate of 10.77%. During the three and nine months ended September 30, 2023, the Company recorded interest income related to notes receivable of $0.3 million and $0.9 million, respectively. During the three and nine months ended September 30, 2022, the Company recorded interest income of $0.3 million and $1.0 million, respectively. Interest income is recorded in other income, net in the condensed consolidated statements of operations. Stated maturities of the notes receivable are as follows as of September 30, 2023: Year Expected principal payments (in thousands) Remainder of 2023 $ 263 2024 6,033 2025 6,868 2026 — 2027 — Thereafter — Total 13,164 Less: discount on notes receivable (56) Total $ 13,108

Inventories

Inventories	9 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
Inventories	INVENTORIES Inventories are stated at the lower of cost or market. Fixed costs associated with abnormal production volume are expensed as incurred. Inventories are comprised of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Raw material Cannabis plants $ 17,161 $ 21,523 Packaging and supplies 40,896 49,650 Total raw material 58,057 71,173 Work in process 117,399 158,448 Finished goods-unmedicated 5,969 7,323 Finished goods-medicated 48,472 39,561 Total inventories $ 229,897 $ 276,505

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Property And Equipment	PROPERTY AND EQUIPMENT As of September 30, 2023 and December 31, 2022, property and equipment consisted of the following: September 30, 2023 December 31, 2022 (in thousands) Land $ 30,835 $ 38,485 Buildings and improvements 519,405 497,493 Furniture and equipment 289,796 277,164 Vehicles 838 839 Total 840,874 813,981 Less: accumulated depreciation (181,120) (125,866) Total property and equipment 659,754 688,115 Construction in progress 27,824 55,145 Total property and equipment, net $ 687,578 $ 743,260 The Company incurred the following expense related to property and equipment during the three and nine months ended September 30, 2023: Three Months Ended September 30, Nine Months Ended September 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Capitalized interest Interest expense $ 909 $ (1,366) $ 114 $ (4,006) Depreciation expense Cost of goods sold and Depreciation and amortization 18,684 18,820 57,015 51,596 Total $ 19,593 $ 17,454 $ 57,129 $ 47,590 Three Months Ended September 30, Nine Months Ended September 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Loss on impairment Impairments and disposals of long-lived assets, net $ — $ 296 $ 2,712 $ 626 Loss on disposal Impairments and disposals of long-lived assets, net 802 46,064 4,469 54,031 Total $ 802 $ 46,360 $ 7,181 $ 54,657

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	INTANGIBLE ASSETS The Company's definite-lived intangible assets consisted of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value (in thousands) (in thousands) Licenses $ 1,046,544 $ 141,635 $ 904,909 $ 1,044,161 $ 89,367 $ 954,794 Trademarks 27,430 16,418 11,012 27,430 12,530 14,900 Internal use software 24,226 6,260 17,966 16,528 3,065 13,463 Tradenames 4,861 4,321 540 4,862 3,506 1,356 Customer relationships 3,535 3,402 133 3,536 3,252 284 Total $ 1,106,596 $ 172,036 $ 934,560 $ 1,096,517 $ 111,720 $ 984,797 Amortization expense was $20.2 million and $60.3 million for the three and nine months ended September 30, 2023, respectively, and $20.9 million and $62.0 million for the three and nine months ended September 30, 2022, respectively. During the nine months ended September 30, 2023, the Company recorded a gain on sale of intangible assets of $3.0 million, which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations. The following table outlines the estimated future amortization expense related to intangible assets as of September 30, 2023: Year Estimated (in thousands) Remainder of 2023 $ 20,375 2024 80,601 2025 77,390 2026 74,669 2027 72,166 Thereafter 609,359 $ 934,560

Held for Sale

Held for Sale	9 Months Ended
	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Held for Sale	HELD FOR SALE As of September 30, 2023, the Company had $22.1 million in assets held for sale, which are recorded in prepaids and other current assets on the condensed consolidated balance sheets, and primarily consist of property and equipment. As of December 31, 2022, the Company had $14.5 million in assets held for sale which primarily consisted of property and equipment. (in thousands) Held for sale assets as of December 31, 2022 $ 14,521 Assets moved to held for sale 18,683 Non-cash settlement (2,481) Impairments (2,611) Assets sold (5,968) Held for sale assets as of September 30, 2023 $ 22,144 Held for sale liabilities as of December 31, 2022 $ — Liabilities moved to held for sale (1,997) Liabilities settled associated with held for sale assets 1,997 Held for sale liabilities as of September 30, 2023 $ — During the three and nine months ended September 30, 2023, the Company recorded a loss on the impairment and disposal of held for sale assets of $1.0 million and $3.6 million, respectively, and $2.5 million and $5.1 million during the three and nine months ended September 30, 2022, respectively, which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations. The assets and liabilities associated with discontinued operations consisted of the following as September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Assets associated with discontinued operations Cash $ 94 $ 5,702 Accounts receivable, net 2,686 2,936 Inventories — 21,310 Income tax receivable 2,554 2,299 Prepaids expenses and other current assets 880 1,486 Deferred tax asset — 766 Property and equipment, net — 53,687 Right of use assets - operating, net — 2,453 Right of use assets - finance, net — 5,736 Intangible assets, net — 27,849 Other assets 2,010 2,638 Total assets associated with discontinued operations $ 8,224 $ 126,862 Liabilities associated with discontinued operations Accounts payable and accrued liabilities $ 870 $ 1,617 Deferred revenue — 109 Operating lease liabilities - current portion 158 146 Finance lease liabilities - current portion 343 456 Construction finance liability - current portion 1,897 — Operating lease liabilities 15,366 17,108 Finance lease liabilities 2,527 5,890 Construction finance liability 24,717 45,217 Other long-term liabilities 6 155 Total liabilities associated with discontinued operations $ 45,884 $ 70,698 The following table summarizes the Company's loss from discontinued operations for the three and nine months ended September 30, 2023 and 2022. The gain and loss resulting from the forgiveness of intercompany payables has been eliminated in consolidation. Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Revenue $ 2,332 $ 6,031 $ 10,679 $ 20,262 Cost of goods sold 2,812 8,006 29,843 25,238 Gross margin (480) (1,975) (19,164) (4,976) Expenses: Operating expenses 916 3,051 5,298 9,100 Impairment and disposal of long-lived assets, net 565 49,069 69,840 49,069 Total Expenses 1,481 52,120 75,138 58,169 Loss from operations (1,961) (54,095) (94,302) (63,145) Other (expense) income: Interest expense, net (971) (1,533) (4,149) (4,590) Other income, net — 30 22 90 Total other expense, net (971) (1,503) (4,127) (4,500) Loss before provision for income taxes (2,932) (55,598) (98,429) (67,645) Income tax (provision) benefit 5 13,152 (625) 14,467 Net loss from discontinued operations, net of tax (provision) benefit (2,927) (42,446) (99,054) (53,178) Less: Net loss attributable to non-controlling interest from discontinued operations — — (1,193) — Net loss from discontinued operations excluding non-controlling interest $ (2,927) $ (42,446) $ (97,861) $ (53,178) The condensed consolidated statements of cash flows include continuing operations and discontinued operations. The following table summarizes the depreciation of long-lived assets, amortization of long-lived assets, and capital expenditures of discontinued operations for the three and nine months ended September 30, 2023 and 2022. Nine Months Ended September 30, 2023 2022 Depreciation and amortization $ 3,798 $ 8,707 Purchases of property plant and equipment $ 67 $ 799 Loss on impairment of long-lived assets $ 69,840 $ 49,069 Other noncash investing and financing activities Noncash partial extinguishment of construction finance liability $ 18,486 $ — As a result of our exit from the Massachusetts market during the second quarter of 2023, the Company performed a lease term reassessment for the Holyoke failed sale-leaseback financing arrangement due to lease renewals previously included in the lease term being excluded as of the Massachusetts exit. The Company concluded the failed sale-leaseback accounting conclusion is maintained. The Company recognized a gain on partial extinguishment of $18.5 million as a result of the lease term reassessment, which partially offset the loss on disposal of the related property and improvements of $45.8 million which is recorded to net loss from discontinued operations, net of tax (provision) benefit. Future minimum lease payments for the construction finance liability as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ 1,347 2024 5,455 2025 5,619 2026 5,788 2027 5,961 Thereafter 18,427 Total future payments 42,597 Less: Interest (15,983) Total present value of minimum payments 26,614 Construction finance liability - current portion (1,897) Construction finance liability $ 24,717

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Notes Payable	NOTES PAYABLE As of September 30, 2023 and December 31, 2022, notes payable consisted of the following: September 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Maturity Date Net Book Value of (in thousands) Promissory notes dated December 21, 2022 (1) $ 70,454 $ 71,500 7.53% (4) 7.86% 1/1/2028 $ 154,306 Promissory note dated December 22, 2022 (2) 18,582 18,900 7.30% (4) 7.38% 12/22/2032 $ 9,193 Promissory notes dated October 1, 2021 (3) 5,751 6,095 8.14% (4) 8.29% 10/1/2027 $ 11,860 Promissory note dated December 22, 2022 5,500 5,500 10.00% (4) 10.00% 12/22/2023 (5) Promissory notes acquired in October 2021 1,743 5,338 (6) (4) (6) (6) (6) Promissory note of consolidated variable-interest entity dated February 1, 2022 982 1,200 8.00% (4) 8.00% 12/31/2025 — Total notes payable 103,012 108,533 Less: debt discount (1,586) (1,833) Less: current portion of notes payable (9,117) (12,453) Notes payable, net (7) $ 92,309 $ 94,247 (1) In connection with the closing of these four promissory notes, the Company entered into an interest rate swap to fix the interest rate at 7.53% for the term of the notes. See Note 23 in the 2022 Form 10-K for further details. These promissory notes contain customary restrictive covenants pertaining to our management and operations, including, among other things, limitations on the amount of debt that may be incurred and the ability to pledge assets, among other things, as well as financial covenant requirements, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, debt service coverage ratio, and liquidity covenant test. The covenants commence on September 30, 2023 and are measured semi-annually, except for certain covenants which were measured starting as of December 31, 2022. In May 2023, the Company amended the terms of the agreement in respect to the covenant requirements, excluding balloon payments from certain covenant calculations. (2) Promissory note bears interest at 7.30% per annum until December 21, 2027. Thereafter, interest will accrue at a rate equal to the five-year treasury rate in effect as of December 12, 2027 plus 3.50%. The promissory note contains customary restrictive covenants pertaining to our operations, including, among other things, limitations on the amount of debt and subsidiary debt that may be incurred and the ability to pledge assets, as well as financial covenant requirements, among other things, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, covenant to liquidity and debt principal test, and a global debt service coverage ratio. (3) On November 15, 2022, the Company closed on the refinancing of our promissory notes dated October 1, 2021 to extend the maturity date by five years and fix the interest rate at 8.14%. During the three months ended March 31, 2023, the Company reclassified the collateralized assets to held for sale as part of its continued efforts to optimize our assets and resources in the markets the Company serves. The Company expects to sell the assets, which primarily consist of property and equipment, within the near-term. (4) Interest payments are due monthly. (5) Promissory note is secured by the acquired membership interest in Formula 420 Cannabis LLC. See Note 4 in the 2022 Form 10-K fo r further details . (6) Seven promissory notes were acquired during the year ending December 31, 2021. Interest rates range from 0.00% to 7.00%, with a weighted average interest rate of 6.28% as of September 30, 2023. Maturity dates range from October 2023 to April 2026. Of the seven acquired promissory notes, three remain outstanding as of September 30, 2023. The three notes are secured by various assets that approximate the value of the underlying notes of $1.7 million as of September 30, 2023. (7) In addition to the notes payable listed in the above table, the Company entered into a letter of credit in October 2022 for up to $1.5 million, for which there have been no draws as of September 30, 2023. The letter of credit was payable on demand, had an interest rate of 6.25%, and expired undrawn in October 2023. During the three and nine months ended September 30, 2023, the Company incurred interest expense related to these notes payable of $2.1 million and $6.3 million, respectively, and during the three and nine months ended September 30, 2022, the Company incurred interest expense of $0.2 million and $0.5 million, respectively, which is included within interest expense in the condensed consolidated statements of operations. This includes accretion expense of $0.1 million and $0.3 million, respectively, for the three and nine months ended September 30, 2023. Accretion expense for the three and nine months ended September 30, 2022 was nominal and $0.1 million, respectively. The Company's notes payable described above are subordinated to the private placement notes. See Note 10. Private Placement Notes for further details. As of September 30, 2023, stated maturities of notes payable are as follows: (in thousands) Remainder of Current year end $ 7,158 2024 3,232 2025 3,825 2026 3,044 2027 69,352 Thereafter 16,401 Total $ 103,012

Private Placement Notes

Private Placement Notes	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Private Placement Notes	PRIVATE PLACEMENT NOTES June and November Notes In 2019, the Company completed two private placement arrangements (the “June Notes” and the “November Notes”), each comprised of 5-year senior secured promissory notes with a face value of $70.0 million and $60.0 million, respectively. The purchasers of the June Notes received warrants to purchase 1,470,000 Subordinate Voting Shares at a price of $13.47 ("June Warrants") and the purchasers of the November Notes received warrants to purchase 1,560,000 Subordinate Voting Shares at a price of $980 per Unit, with each unit consisting of one Note issued in Denominations of $1,000 and 26 warrants ("November Warrants"), which can be exercised for approximately three years after closing (collectively the "Public Warrants"). The remaining outstanding Public Warrants expired in June 2022. 2026 Notes On October 6, 2021, the Company closed its private placement of 8% Senior Secured Notes (the "2026 Notes - Tranche One") for aggregate gross proceeds of $350.0 million and net proceeds of $342.6 million. The Company used a portion of the net proceeds to repay certain outstanding acquired indebtedness and used the remaining net proceeds for capital expenditures and other general corporate purposes. On January 28, 2022, the Company closed on a second tranche private placement of 8% Senior Secured Notes (the "2026 Notes - Tranche Two") for aggregate gross proceeds of $76.9 million and net proceeds of $75.6 million. The Company used the net proceeds for capital expenditures and other general corporate purposes. The notes may be redeemed in whole or in part, at the Company's option, at any time, on or after October 6, 2023, at the applicable redemption price. These notes are collectively referred to as the "2026 Notes". During the three months ended September 30, 2023, the Company made an open market repurchase of its 2026 Notes - Tranche One, that resulted in the extinguishment of $57.0 million in principal at a discount of 16.5%. Total cash consideration paid to repurchase the $57.0 million principal amount outstanding, excluding accrued interest, totaled $48.0 million, and the Company recognized a gain of $8.2 million on the extinguishment of debt during the three and nine months ended September 30, 2023. As of September 30, 2023 and December 31, 2022, private placement notes payable consisted of the following: September 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Rate Maturity Date (in thousands) 2026 Notes - Tranche One $ 293,000 $ 350,000 8.00% 8.52% 10/6/2026 2026 Notes - Tranche Two 75,000 75,000 8.00% 8.43% 10/6/2026 June Notes 70,000 70,000 9.75% 13.32% 6/11/2024 November Notes 60,000 60,000 9.75% 13.43% 6/11/2024 Total private placement notes 498,000 555,000 Less: Unamortized debt discount and issuance costs (8,263) (13,336) Less: current portion of private placement notes, net (126,908) — Private placement notes, net $ 362,829 $ 541,664 The private placement notes contain customary restrictive covenants pertaining to our management and operations, including, among other things, limitations on the amount of debt that may be incurred and the ability to pledge assets, as well as financial covenant requirements, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements and a fixed charge ratio coverage, measured from time to time when certain conditions are met. During the three and nine months ended September 30, 2023, the Company incurred interest expense related to private placement notes of $13.2 million and $39.1 million, respectively, and during the three and nine months ended September 30, 2022, the Company incurred interest expense of $13.1 million and $38.9 million, respectively, which is included within interest expense in the condensed consolidated statements of operations related to the private placement notes. This includes accretion expense on the private placement notes of $1.5 million and $4.3 million, respectively, for the three and nine months ended September 30, 2023 and $1.3 million and $3.8 million, respectively, for the three and nine months ended September 30, 2022. Stated maturities of the principal portion of private placement notes outstanding as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ — 2024 130,000 2025 — 2026 368,000 2027 — Thereafter — Total private placement notes $ 498,000

Leases

Leases	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	LEASESThe Company leases real estate used for dispensaries, cultivation and production facilities, and corporate offices. Lease terms for real estate generally range from five three Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for taxes, insurance and maintenance which are considered non-lease components. The Company accounts for real estate leases and the related fixed non-lease components together as a single component. The Company recorded a loss on disposal of right of use assets of $6.1 million and $16.6 million for the three and nine months ended September 30, 2022, which is the result of repositioning of assets in the southeast, which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations. The loss on disposal of right of use assets for the three and nine months ended September 30, 2023 was nominal. During the three and nine months ended September 30, 2023, the Company recorded a net gain on lease terminations of $5.9 million. During the three and nine months ended September 30, 2022, the Company recorded a net gain on lease terminations of $0.3 million. The following table provides the components of lease cost recognized within the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022: Three Months Ended Nine Months Ended September 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Operating lease cost Cost of goods sold, sales and marketing, general and administrative $ 5,109 $ 5,391 $ 15,249 $ 16,310 Finance lease cost: Amortization of lease assets Cost of goods sold and Depreciation and amortization 2,527 2,942 7,886 7,928 Interest on lease liabilities Interest expense 1,632 1,693 4,854 4,749 Finance lease cost 4,159 4,635 12,740 12,677 Variable lease cost Cost of goods sold, sales and marketing, general and administrative 1,897 1,816 6,613 5,591 Short term lease expense Cost of goods sold, sales and marketing, general and administrative 37 201 406 456 Total lease cost $ 11,202 $ 12,043 $ 35,008 $ 35,034 Other information related to operating and finance leases is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,612 $ 5,401 $ 14,616 $ 15,511 Operating cash flows from finance leases $ 1,621 $ 1,695 $ 4,888 $ 4,742 Financing cash flows from finance leases $ 1,751 $ 1,925 $ 5,423 $ 4,999 ASC 842 lease additions and modifications: Operating leases $ 706 $ 2,707 $ 11,714 $ 14,677 Finance leases $ 901 $ — $ 1,018 $ 18,413 September 30, 2023 December 31, 2022 Weighted average discount rate: Operating leases 10.08 % 9.29 % Finance leases 9.23 % 8.66 % Weighted average remaining lease term (in years): Operating leases 9.1 8.3 Finance leases 7.6 7.8 Future minimum lease payments under the Company's non-cancellable leases as of September 30, 2023 are as follows: Operating Leases Finance Leases (in thousands) Remainder of 2023 $ 4,636 $ 3,416 2024 19,236 13,811 2025 19,185 13,588 2026 18,481 12,789 2027 17,831 11,895 Thereafter 73,277 44,743 Total undiscounted lease liabilities 152,646 100,242 Less: Interest (50,338) (29,063) Total present value of minimum lease payments 102,308 71,179 Lease liabilities- current portion (9,697) (7,537) Lease liabilities $ 92,611 $ 63,642 Lease Guarantees In accordance with ASC 460, Guarantees, the Company has determined that it meets the guarantor requirements under certain contractual agreements. During the three months ended September 30, 2023, the Company terminated a retail lease resulting in the Company being relieved of its primary obligation under this lease. As a result of the lease termination, a new tenant executed a new lease for the same property with the Company becoming secondarily liable. Nonperformance by the new tenant results in the Company becoming obligated to fulfill the lease conditions. The new lease has a term of approximately 6 years from September 30, 2023 with the Company serving as guarantor for an approximate term of 6 years. If the new tenant defaults on the lease obligations the Company becomes responsible for payment. The resulting maximum exposure includes $5.4 million of undiscounted future minimum lease payments plus potential additional payments to satisfy maintenance, taxes, and insurance requirements under the remaining 6 years the Company is guarantor.
Leases	LEASESThe Company leases real estate used for dispensaries, cultivation and production facilities, and corporate offices. Lease terms for real estate generally range from five three Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for taxes, insurance and maintenance which are considered non-lease components. The Company accounts for real estate leases and the related fixed non-lease components together as a single component. The Company recorded a loss on disposal of right of use assets of $6.1 million and $16.6 million for the three and nine months ended September 30, 2022, which is the result of repositioning of assets in the southeast, which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations. The loss on disposal of right of use assets for the three and nine months ended September 30, 2023 was nominal. During the three and nine months ended September 30, 2023, the Company recorded a net gain on lease terminations of $5.9 million. During the three and nine months ended September 30, 2022, the Company recorded a net gain on lease terminations of $0.3 million. The following table provides the components of lease cost recognized within the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022: Three Months Ended Nine Months Ended September 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Operating lease cost Cost of goods sold, sales and marketing, general and administrative $ 5,109 $ 5,391 $ 15,249 $ 16,310 Finance lease cost: Amortization of lease assets Cost of goods sold and Depreciation and amortization 2,527 2,942 7,886 7,928 Interest on lease liabilities Interest expense 1,632 1,693 4,854 4,749 Finance lease cost 4,159 4,635 12,740 12,677 Variable lease cost Cost of goods sold, sales and marketing, general and administrative 1,897 1,816 6,613 5,591 Short term lease expense Cost of goods sold, sales and marketing, general and administrative 37 201 406 456 Total lease cost $ 11,202 $ 12,043 $ 35,008 $ 35,034 Other information related to operating and finance leases is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,612 $ 5,401 $ 14,616 $ 15,511 Operating cash flows from finance leases $ 1,621 $ 1,695 $ 4,888 $ 4,742 Financing cash flows from finance leases $ 1,751 $ 1,925 $ 5,423 $ 4,999 ASC 842 lease additions and modifications: Operating leases $ 706 $ 2,707 $ 11,714 $ 14,677 Finance leases $ 901 $ — $ 1,018 $ 18,413 September 30, 2023 December 31, 2022 Weighted average discount rate: Operating leases 10.08 % 9.29 % Finance leases 9.23 % 8.66 % Weighted average remaining lease term (in years): Operating leases 9.1 8.3 Finance leases 7.6 7.8 Future minimum lease payments under the Company's non-cancellable leases as of September 30, 2023 are as follows: Operating Leases Finance Leases (in thousands) Remainder of 2023 $ 4,636 $ 3,416 2024 19,236 13,811 2025 19,185 13,588 2026 18,481 12,789 2027 17,831 11,895 Thereafter 73,277 44,743 Total undiscounted lease liabilities 152,646 100,242 Less: Interest (50,338) (29,063) Total present value of minimum lease payments 102,308 71,179 Lease liabilities- current portion (9,697) (7,537) Lease liabilities $ 92,611 $ 63,642 Lease Guarantees In accordance with ASC 460, Guarantees, the Company has determined that it meets the guarantor requirements under certain contractual agreements. During the three months ended September 30, 2023, the Company terminated a retail lease resulting in the Company being relieved of its primary obligation under this lease. As a result of the lease termination, a new tenant executed a new lease for the same property with the Company becoming secondarily liable. Nonperformance by the new tenant results in the Company becoming obligated to fulfill the lease conditions. The new lease has a term of approximately 6 years from September 30, 2023 with the Company serving as guarantor for an approximate term of 6 years. If the new tenant defaults on the lease obligations the Company becomes responsible for payment. The resulting maximum exposure includes $5.4 million of undiscounted future minimum lease payments plus potential additional payments to satisfy maintenance, taxes, and insurance requirements under the remaining 6 years the Company is guarantor.

Construction Finance Liabilitie

Construction Finance Liabilities	9 Months Ended
	Sep. 30, 2023
Construction Finance Liability [Abstract]
Construction Finance Liabilities	CONSTRUCTION FINANCE LIABILITIESWhen the Company enters into sale-leaseback transactions, it assesses whether a contract exists and whether there is a performance obligation to transfer control of the asset when determining whether the transfer of an asset shall be accounted for as a sale of the asset. If control is not transferred, based on the nature of the transaction, and therefore does not meet the requirements for a sale under the failed-sale-leaseback accounting model, the Company is deemed to own this real estate and reflects these properties on its consolidated balance sheets in property and equipment, net and depreciates them over the assets' useful lives. The liabilities associated with these leases are recorded to construction finance liabilities - current portion and construction finance liabilities on the condensed consolidated balance sheets. During the three and nine months ended September 30, 2023, the Company recorded interest expense of $4.1 million and $12.3 million, respectively, and during the three and nine months ended September 30, 2022, the Company recorded interest expense of $4.1 million and $11.8 million, respectively, related to construction finance liabilities, which is included in interest expense within the condensed consolidated statements of operations. Ben Bostic In October 2019, the Company sold property in Florida in exchange for cash of $17.0 million. Concurrent with the closing of the purchase, the buyer entered into a lease agreement with the Company, for continued operation as a licensed medical cannabis cultivation facility. Control was never transferred to the buyer-lessor because the transaction was determined to be a finance lease and did not meet the requirements of a sale. The transaction was treated as a failed sale-leaseback financing arrangement. As of September 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $17.8 million and $17.7 million, respectively. McKeesport In October 2019, the Company acquired a failed sales-leaseback transaction of a cannabis cultivation facility in Pennsylvania. The initial term of the lease is 15 years, with two five-year options to renew. As of September 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $42.3 million and $41.8 million, respectively. Alachua In October 2021, the Company acquired a failed sales-leaseback transaction of a cannabis cultivation and processing facility in Florida. The lease originated in January 2021 and has an initial term of 20 years, with two five-year options to renew. In the third quarter of 2022, the Company ceased using this facility and as a result recorded a loss on disposal of the related property and equipment of $42.4 million. As of September 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $59.3 million and $59.2 million, respectively. Hancock In October 2021, the Company acquired a failed sales-leaseback transaction of a cannabis cultivation and processing facility in Maryland. The lease originated in August 2021 and has an initial term of ten years with two options to extend the term, the first providing a ten-year renewal option and the second providing a five-year renewal option. The landlord has agreed to provide a tenant improvement allowance of $12.9 million as an additional component of base rent. As of September 30, 2023, and December 31, 2022, $12.7 million and $12.3 million of the tenant improvement allowance has been provided, respectively. As of September 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $18.8 million and $19.7 million, respectively. Future minimum lease payments for the construction finance liabilities as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ 4,186 2024 17,043 2025 17,521 2026 18,013 2027 18,519 Thereafter 302,424 Total future payments 377,706 Less: Interest (239,490) Total present value of minimum payments 138,216 Construction finance liabilities - current portion (1,393) Construction finance liabilities $ 136,823

Share Based Compensation

Share Based Compensation	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Share Based Compensation	SHARE BASED COMPENSATION Equity Incentive Plans The Company’s 2021 Omnibus Incentive Plan, as Amended and Restated (the “2021 Plan”) was adopted at the annual meeting of shareholders. The 2021 Plan reserves 10,000,000 Subordinate Voting Shares for issuance thereunder and replaced the Schyan Exploration Inc. Stock Option Plan (the “Prior Plan”). Options On July 25, 2023, under the 2021 Plan, the Board awarded options to purchase shares to board members, officers, and key employees of the Company. The options granted to board members vest immediately and all other options granted to employees vest over a three-year period. In determining the amount of share-based compensation related to options issued during the three months ending September 30, 2023, the Company used the Black-Scholes pricing model to establish the fair value of the options granted with the following assumptions: For the Three Months Ended September 30, 2023 Stock price at grant date $3.99 Exercise price at grant date $3.99 Expected life in years 3.30 - 3.97 Expected volatility 60.07 % - 60.85% Expected annual rate of dividends 0.00% Risk free annual interest rate 4.34 % - 4.53% The expected volatility was estimated by using the historical volatility of the Company. The expected life in years represents the period of time that options granted are expected to be outstanding and is computed using the simplified method as the Company has insufficient historical information regarding its stock options to provide a basis for an estimate. The risk-free rate was based on the United States bond yield rate at the time of grant of the award. The expected annual rate of dividends is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. The Company has elected to account for forfeitures as they occur. The Company recorded share-based compensation for stock options as follows: Three Months Ended September 30, Nine Months Ended September 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 19 $ 90 $ 54 $ 138 General and administrative 1,766 1,756 2,235 6,179 Sales and marketing 13 77 46 350 Total share-based compensation expense $ 1,798 $ 1,923 $ 2,335 $ 6,667 The number and weighted-average exercise prices and remaining contractual life of options as of September 30, 2023 were as follows: Number of options Weighted average exercise price Weighted average grant-date fair value Weighted average remaining contractual life (Yrs.) Aggregate intrinsic value Outstanding, January 1, 2023 3,177,815 $ 25.96 5.41 $ — Granted 1,754,817 — $ 1.98 Exercised — — Forfeited (400,388) 29.33 Outstanding, September 30, 2023 4,532,244 $ 17.15 5.12 $ — Exercisable, September 30, 2023 2,332,221 $ 24.24 3.59 $ — As of September 30, 2023, there was approximately $3.7 million of unrecognized compensation cost related to unvested stock option arrangements which is expected to be recognized over a weighted average service period of 0.73 years. Restricted Stock Units On July 25, 2023, the Board awarded RSUs to board members, officers, and other key employees of the Company. The RSUs vest over a 30-day period for board members and all other RSUs granted vest over a two-year period. The fair value of RSUs is determined on the grant date and is amortized over the vesting period. The following is a summary of RSU activity for the nine months ended September 30, 2023 Number of Weighted average Unvested balance as of January 1, 2023 720,707 $ 22.36 Granted 2,955,177 3.99 Vested (80,521) 3.99 Forfeited (309,132) 11.21 Unvested balance as of September 30, 2023 3,286,231 $ 7.34 The Company recorded share-based compensation for RSUs as follows: Three Months Ended September 30, Nine Months Ended September 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 231 $ 302 $ 491 $ 761 General and administrative 2,284 2,011 4,204 6,463 Sales and marketing 226 56 385 668 Total share-based compensation expense $ 2,741 $ 2,369 $ 5,080 $ 7,892 As of September 30, 2023, there was approximately $12.7 million of total unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average service period of 0.88 years.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE The following is a reconciliation for the calculation of basic and diluted earnings per share: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator (in thousands, except share and per share amounts) Continuing operations Net loss from continuing operations $ (22,916) $ (72,626) $ (399,292) $ (118,397) Less: Net loss attributable to non-controlling interest (451) (518) (3,788) (2,555) Net loss from continuing operations available to common shareholders of Trulieve Cannabis Corp. $ (22,465) $ (72,108) $ (395,504) $ (115,842) Discontinued operations Net loss from discontinued operations $ (2,927) $ (42,446) $ (99,054) $ (53,178) Less: Net loss attributable to non-controlling interest — — (1,193) — Net loss from discontinued operations excluding non-controlling interest $ (2,927) $ (42,446) $ (97,861) $ (53,178) Denominator Weighted average number of common shares outstanding - Basic and diluted 188,924,694 188,597,094 188,959,454 187,549,359 Loss per Share - Continuing operations Basic and diluted loss per share $ (0.12) $ (0.38) $ (2.09) $ (0.63) Loss per Share - Discontinued operations Basic and diluted loss per share $ (0.02) $ (0.23) $ (0.52) $ (0.28) Shares which have been excluded from diluted per share amounts because their effect would have been anti-dilutive are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Stock options 4,532,244 3,289,663 3,500,810 3,461,280 Restricted share units 3,286,231 901,689 1,532,393 1,005,259 Warrants 9,496 767,499 65,461 1,723,676 As of September 30, 2023, there are approximately 186.0 million issued and outstanding shares which excludes approximately 2.9 million fully vested RSUs which are not contractually issuable until 2024 and approximately 0.1 million fully vested RSUs which are not contractually issuable until the earlier of a triggering event, as defined, or December 1, 2030.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES The following table summarizes the Company’s income tax expense and effective tax rate for the three and nine months ended September 30, 2023 and 2022. Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Income (loss) before provision for income taxes $13,724 $(44,256) $(293,359) $(1,627) Provision for income taxes $36,640 $28,370 $105,933 $116,770 Effective tax rate 267% (64%) (36%) (7177%) The Company has computed its provision for income taxes based on the actual effective tax rate for the quarter as the Company believes this is the best estimate for the annual effective tax rate. The Company is subject to income taxes in the United States and Canada. Significant judgment is required in evaluating the Company’s uncertain tax positions and determining the provision for income taxes. The Company recognizes benefits from uncertain tax positions based on the cumulative probability method whereby the largest benefit with a cumulative probability of greater than 50% is recorded. An uncertain tax position is not recognized if it has less than a 50% likelihood of being sustained. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: September 30, 2023 (in thousands) Balance as of January 1, 2023 $ 41,781 Additions based on tax positions related to the prior year 321,748 Additions based on tax positions related to the current year 107,013 Ending Balance as of September 30, 2023 $ 470,542 The Company’s net uncertain tax liabilities, inclusive of interest and penalties and tax payments on deposit, were approximately $81.4 million and $19.5 million as of September 30, 2023 and December 31, 2022, respectively, which is recorded in other long-term liabilities in the condensed consolidated balance sheets. The increase of $62.0 million in uncertain tax positio ns is primarily due to tax positions based on legal interpretations that challenge the Company's tax liability under IRC Section 280E. As a result, effective September 30, 2023, the Company changed estimates in the income tax provision, resulting in a new uncertain tax position (net) of $49.4 million. The remainder of the change is due to a tax position taken relating to our inventory costs for tax purposes in our Florida and West Virginia dispensaries and interest and penalties on positions taken, resulting in a change of $12.5 million. During the nine months ended September 30, 2023 , the Company recorded interest of $2.2 million and no penalties on uncertain tax liabilities in the consolidated statements of operations and comprehensive income. During the nine months ended September 30, 2022, the Company recorded interest of $0.3 million and no penalties on uncertain tax liabilities in the consolidated statements of operations and comprehensive income. As of September 30, 2023

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	HELD FOR SALE As of September 30, 2023, the Company had $22.1 million in assets held for sale, which are recorded in prepaids and other current assets on the condensed consolidated balance sheets, and primarily consist of property and equipment. As of December 31, 2022, the Company had $14.5 million in assets held for sale which primarily consisted of property and equipment. (in thousands) Held for sale assets as of December 31, 2022 $ 14,521 Assets moved to held for sale 18,683 Non-cash settlement (2,481) Impairments (2,611) Assets sold (5,968) Held for sale assets as of September 30, 2023 $ 22,144 Held for sale liabilities as of December 31, 2022 $ — Liabilities moved to held for sale (1,997) Liabilities settled associated with held for sale assets 1,997 Held for sale liabilities as of September 30, 2023 $ — During the three and nine months ended September 30, 2023, the Company recorded a loss on the impairment and disposal of held for sale assets of $1.0 million and $3.6 million, respectively, and $2.5 million and $5.1 million during the three and nine months ended September 30, 2022, respectively, which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations. The assets and liabilities associated with discontinued operations consisted of the following as September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Assets associated with discontinued operations Cash $ 94 $ 5,702 Accounts receivable, net 2,686 2,936 Inventories — 21,310 Income tax receivable 2,554 2,299 Prepaids expenses and other current assets 880 1,486 Deferred tax asset — 766 Property and equipment, net — 53,687 Right of use assets - operating, net — 2,453 Right of use assets - finance, net — 5,736 Intangible assets, net — 27,849 Other assets 2,010 2,638 Total assets associated with discontinued operations $ 8,224 $ 126,862 Liabilities associated with discontinued operations Accounts payable and accrued liabilities $ 870 $ 1,617 Deferred revenue — 109 Operating lease liabilities - current portion 158 146 Finance lease liabilities - current portion 343 456 Construction finance liability - current portion 1,897 — Operating lease liabilities 15,366 17,108 Finance lease liabilities 2,527 5,890 Construction finance liability 24,717 45,217 Other long-term liabilities 6 155 Total liabilities associated with discontinued operations $ 45,884 $ 70,698 The following table summarizes the Company's loss from discontinued operations for the three and nine months ended September 30, 2023 and 2022. The gain and loss resulting from the forgiveness of intercompany payables has been eliminated in consolidation. Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Revenue $ 2,332 $ 6,031 $ 10,679 $ 20,262 Cost of goods sold 2,812 8,006 29,843 25,238 Gross margin (480) (1,975) (19,164) (4,976) Expenses: Operating expenses 916 3,051 5,298 9,100 Impairment and disposal of long-lived assets, net 565 49,069 69,840 49,069 Total Expenses 1,481 52,120 75,138 58,169 Loss from operations (1,961) (54,095) (94,302) (63,145) Other (expense) income: Interest expense, net (971) (1,533) (4,149) (4,590) Other income, net — 30 22 90 Total other expense, net (971) (1,503) (4,127) (4,500) Loss before provision for income taxes (2,932) (55,598) (98,429) (67,645) Income tax (provision) benefit 5 13,152 (625) 14,467 Net loss from discontinued operations, net of tax (provision) benefit (2,927) (42,446) (99,054) (53,178) Less: Net loss attributable to non-controlling interest from discontinued operations — — (1,193) — Net loss from discontinued operations excluding non-controlling interest $ (2,927) $ (42,446) $ (97,861) $ (53,178) The condensed consolidated statements of cash flows include continuing operations and discontinued operations. The following table summarizes the depreciation of long-lived assets, amortization of long-lived assets, and capital expenditures of discontinued operations for the three and nine months ended September 30, 2023 and 2022. Nine Months Ended September 30, 2023 2022 Depreciation and amortization $ 3,798 $ 8,707 Purchases of property plant and equipment $ 67 $ 799 Loss on impairment of long-lived assets $ 69,840 $ 49,069 Other noncash investing and financing activities Noncash partial extinguishment of construction finance liability $ 18,486 $ — As a result of our exit from the Massachusetts market during the second quarter of 2023, the Company performed a lease term reassessment for the Holyoke failed sale-leaseback financing arrangement due to lease renewals previously included in the lease term being excluded as of the Massachusetts exit. The Company concluded the failed sale-leaseback accounting conclusion is maintained. The Company recognized a gain on partial extinguishment of $18.5 million as a result of the lease term reassessment, which partially offset the loss on disposal of the related property and improvements of $45.8 million which is recorded to net loss from discontinued operations, net of tax (provision) benefit. Future minimum lease payments for the construction finance liability as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ 1,347 2024 5,455 2025 5,619 2026 5,788 2027 5,961 Thereafter 18,427 Total future payments 42,597 Less: Interest (15,983) Total present value of minimum payments 26,614 Construction finance liability - current portion (1,897) Construction finance liability $ 24,717

Variable Interest Entities

Variable Interest Entities	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	VARIABLE INTEREST ENTITIES The Company has entered into certain agreements with various entities related to the purchase and operation of cannabis dispensary, cultivation, and production licenses, in several states in which it determined to be variable interest entities. The Company's VIEs are not material to the consolidated financial position or operations as of September 30, 2023 and December 31, 2022 or for the three and nine months ended September 30, 2023 and 2022. The Company determined certain of these entities to be variable interest entities in which it is the primary beneficiary. The Company holds ownership interests in these entities ranging from 46% to 95% either directly or through a proxy as of September 30, 2023. During the three months ended March 31, 2023, the Company paid $0.4 million i n cash and $1.7 million in subordinate voting shares earned but not yet issued, based on the completion of certain milestones required as part of the acquisition of one of the Company's consolidated variable interest entities. The Company previously paid $0.8 million in cash for certain milestones. As part of the Company's decision to exit the Massachusetts market during the three months ended June 30, 2023, it ceased its relationship with this variable interest entity. This terminated the payment of the $1.7 million subordinate voting shares earned but not yet issued. Based on the changes in circumstances, the Company reevaluated the variable interest entity, concluding it was no longer the primary beneficiary and as such, deconsolidated the entity during the three months ended June 30, 2023. The Company recorded a loss of $10.0 million related to the termination of the acquisition and deconsolidation of the variable interest entity which is included in the loss from discontinued operations in the condensed consolidated statements of operations for the ni ne months ended September 30, 2023. During the three months ended June 30, 2023, the Company sold and divested of certain variable interest entities. The Company received cash proceeds of $1.8 million related to the sale and recorded a loss on divestment of $0.8 million which is included in impairments and disposals of long-lived assets, net in the condensed consolidated statements of operations. The activity for the three months ended September 30, 2023 was nominal. The Company no longer consolidates these VIEs since it is no longer considered the primary beneficiary. The following table presents the summarized assets and liabilities of the Company’s VIEs in which the Company does not hold a majority interest as of September 30, 2023 and December 31, 2022. The assets and liabilities in the table below include third-party assets and liabilities of our VIEs only and exclude intercompany balances that eliminate in consolidation as included on our condensed consolidated balance sheets. September 30, 2023 December 31, 2022 (in thousands) Current assets: Cash $ 7,335 $ 7,349 Accounts receivable, net 1,386 597 Inventories 8,730 7,590 Prepaid expenses and other current assets 641 46 Total current assets 18,092 15,582 Property and equipment, net 28,248 25,994 Right of use asset - operating, net 2,781 — Right of use asset - finance, net 278 224 Intangible assets, net 17,496 17,947 Other assets 147 344 Total assets $ 67,042 $ 60,091 Current liabilities: Accounts payable and accrued liabilities $ 2,308 $ 3,713 Income tax payable 2,538 1,615 Deferred revenue 2 6 Operating lease liability - current portion 44 — Finance lease liability - current portion 59 41 Total current liabilities 4,951 5,375 Notes payable 982 1,200 Operating lease liability 2,961 — Finance lease liability 227 185 Deferred tax liabilities 3,663 4,101 Other long-term liabilities 670 625 Total liabilities $ 13,454 $ 11,486

Related Parties

Related Parties	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Parties	RELATED PARTIESThe Company leases a cultivation facility and corporate office facility from an entity that is directly or indirectly owned by the Company's Chief Executive Officer and Chair of the board of directors, a former member of the Company's board of directors, and a member of the Company's board of directors. As of September 30, 2023, and December 31, 2022, under ASC 842, the Company had the following related party operating leases on the condensed consolidated balance sheets: As of September 30, 2023 As of December 31, 2022 (in thousands) Right-of-use assets, net $ 736 $ 820 Lease liabilities: Lease liabilities - current portion $ 123 $ 113 Lease liabilities 658 751 Total related parties lease liabilities $ 781 $ 864 Lease expense recognized on related party operating leases was less than $0.1 million and $0.1 million for the three and nine months ended September 30, 2023, respectively. Lease expense was less than $0.1 million and $0.2 million for the three and nine months ended September 30, 2022, respectively. During the three months ended September 30, 2023, the Company entered into an agreement to rent a piece of equipment from an entity that is directly owned in part by the Company’s Chief Executive Officer and Chair of the board of directors. The expense recognized was nominal for the three and nine months ended September 30, 2023, respectively.

Revenue Disaggregation

Revenue Disaggregation	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue Disaggregation	REVENUE DISAGGREGATION Net revenues are comprised of the following for the three and nine months ended September 30, 2023 and 2022: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Retail $ 263,166 $ 282,765 $ 809,899 $ 870,410 Wholesale, licensing, and other 12,044 12,588 32,320 49,343 Revenue $ 275,210 $ 295,353 $ 842,219 $ 919,753

Commitments And Contingencies

Commitments And Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	COMMITMENTS AND CONTINGENCIES Operating Licenses Although the possession, cultivation, and distribution of cannabis is permitted in the states in which the Company operates, cannabis is a Schedule-I controlled substance and its use remains a violation of federal law. Since federal law criminalizing the use of cannabis preempts state laws that legalize its use, strict enforcement of federal law regarding cannabis would likely result in the Company’s inability to proceed with our business plans. In addition, the Company’s assets, including real property, inventory, cash and cash equivalents, equipment, and other goods, could be subject to asset forfeiture because cannabis is still federally illegal. Claims and Litigation In the ordinary course of business, the Company may be a party to litigation, investigations, inquiries, employment-related matters, disputes and other potential claims. As of September 30, 2023, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s condensed consolidated statements of operations. The Company does not believe it is probable that the outcome of any existing litigation, investigations, disputes or other potential claims will materially affect the Company or these financial statements in excess of amounts accrued. In connection with the acquisition of a cultivation operation from CP4 Group, LLC, in Phoenix, Arizona ("Watkins Cultivation Operation" or "Watkins"), in the prior period, the Company received a demand letter on October 12, 2022, related to the four potential earnouts. The earnouts were based on the completion of certain milestones related to construction and operations and contingent on the continued employment of key employee shareholders. The Company entered into a settlement agreement in Q2 2023 closing this matter. During the nine months ended September 30, 2023, escrow of $22.5 million which was included in prepaid and other current assets was released following settlement. Contingencies The Company records contingent liabilities with respect to litigation on various claims in which it believes a loss is probable and can be estimated. As of September 30, 2023 and December 31, 2022, $3.6 million and $31.7 million was included in contingent liabilities on the condensed consolidated balance sheets related to litigation matters, respectively. During the nine months ended September 30, 2023 the Company settled various claims resulting in a decrease to the accrual. As of September 30, 2023 and December 31, 2022, $0.2 million and $3.0 million, respectively, was included in contingent liabilities on the condensed consolidated balance sheets for estimates related to various sales tax matters. Regulatory Compliance The Company’s compliance with state and other rules and regulations may be reviewed by state and federal agencies. If the Company fails to comply with these regulations, the Company could be subject to loss of licenses, substantial fines or penalties, and other sanctions.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSOn November 8, 2023, the Company issued a notice of redemption of the $130.0 million senior secured notes due in June 2024 (the June and November Notes), with a scheduled redemption date of December 1, 2023.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Principles of Consolidation	The accompanying unaudited condensed consolidated financial statements of Trulieve Cannabis Corp., ("Trulieve" and, together with its subsidiaries and variable interest entities, the "Company," "our," or "us") has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and, therefore, do not include all financial information and footnotes required by GAAP for complete financial statements. In management's opinion, the condensed consolidated financial statements include all adjustments of a normal recurring nature necessary to fairly present the Company's financial position as of September 30, 2023, and the results of its operations and cash flows for the periods ended September 30, 2023 and 2022. The results of the Company's operations for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full 2023 fiscal year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for Trulieve Cannabis Corp. and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission ("SEC") on March 8, 2023 (the "2022 Form 10-K").
Discontinued Operations	Discontinued Operations In June 2023, the Company determined to exit our operations in Massachusetts which represented a strategic shift in the business. The related assets and liabilities associated with the Company's discontinued operations are classified as discontinued operations on the condensed consolidated balance sheets and the results of our discontinued operations have been presented as discontinued operations within the condensed consolidated statements of operations for all periods presented. Unless specifically noted otherwise, footnote disclosures reflect the results of continuing operations only. In September 2022, the Company's exit of Nevada was deemed discontinued operations. The results of discontinued operations are presented in Note 16. Discontinued Operations .
Reclassifications	ReclassificationsCertain reclassifications have been made to the condensed consolidated financial statements of prior periods and of the accompanying notes to conform to the current period presentation.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices in active markets, which are observable for the asset or liability, either directly or indirectly; and Level 3 – Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions. The fair values of financial instruments by class are as follows as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (in thousands) Financial Assets: Money market funds (1) $ 164,405 $ — $ — $ 164,405 $ 340 $ — $ — $ 340 Financial Liabilities: Interest rate swap (2) $ — $ 365 $ — $ 365 $ — $ 2,536 $ — $ 2,536 Warrant liabilities (3) $ — $ — $ — $ — $ — $ 252 $ — $ 252 There have been no transfers between hierarchy levels during the periods ending September 30, 2023 or December 31, 2022. (1) Money market funds are included within cash and cash equivalents and restricted cash in the Company’s condensed consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that approximate fair value. The Company recorded interest income of $1.6 million and $3.4 million during the three and nine months ended September 30, 2023 in relation to money market funds. Interest income for the three and nine months ended September 30, 2022 was nominal. Interest income is recorded to other income net, on the condensed consolidated statements of operations. (2) The fair value of the interest rate swap liability is recorded in other long-term liabilities on the condensed consolidated balance sheets. In November 2022 the Company entered into an interest rate swap contract ("VNB Swap") for the purpose of hedging the variability of interest expense and interest payments on the Company's long-term variable debt. The VNB Swap is carried at fair value which is based on a valuation model that utilizes interest rate yield curves and credit spreads observable in active markets as the significant inputs to the model. The Company considers credit risk associated with its own standing as well as the credit standing of any counterparties involved in the valuation of its financial instruments.
Deferred Revenue	Deferred Revenue During the three months ended March 31, 2023, the Company terminated the loyalty program associated with dispensaries acquired with the October 2021 acquisition of Harvest Health & Recreation, Inc. ("Harvest") . As a result of the termination of the loyalty program at certain dispensaries, the Company recorded a reduction in the accrual of $4.7 million in revenue in the condensed consolidated statements of operations. As of September 30, 2023 and December 31, 2022, the loyalty liability totaled $3.0 million and $8.9 million, respectively, and is included in deferred revenue on the condensed consolidated balance sheets. Included within deferred revenue as of September 30, 2023 and December 31, 2022 are customer credit balances of $0.6 million and $0.5 million, respectively.
Impairment of Long-lived Assets	Impairment of Long-Lived Assets The Company reviews long-lived assets, including property and equipment, definite life intangible assets, and right-of-use assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. During the three months ended March 31, 2023, the Company determined that certain long-lived assets, including intangible assets, in Massachusetts were impaired due to the competitive environment in the Massachusetts cannabis industry. The Company utilized a cost approach for its impairment testing of property and equipment resulting in an impairment of $30.3 million, of which $27.6 million relates to discontinued operations and recorded to net loss from discontinued operations, net of tax benefit, and $2.7 million relates to continuing operations recorded in impairment and disposal of long-lived assets, net in the condensed consolidated statements of operations, respectively.
Impairment of Goodwill	Impairment of Goodwill The Company operates as one operating segment and reporting unit and therefore, evaluates goodwill for impairment as one singular reporting unit annually during the fourth quarter or more often when an event occurs, or circumstances indicate the carrying value may not be recoverable. The determination of the fair value of the reporting unit requires us to make significant estimates and assumptions. Due to the inherent uncertainty involved in making these estimates, actual future results could differ. Changes in assumptions regarding future results or other underlying assumptions could have a significant impact on the fair value of the reporting unit. The discounted cash flow model, or the income approach, reflects our estimates of future cash flows and other factors including estimates of future operating performance, including future revenue, long-term growth rates, gross margins, capital expenditures, discount rates and the probability of achieving the estimated cash flows, among others. In addition to the income approach, the Company also employs the market approach in its goodwill impairment testing. Under the market approach, the Company estimates the fair value based upon multiples of comparable public companies. Significant estimates in the market approach include identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, as well as assessing comparable market multiples in estimating the fair value of the reporting unit. During the three months ending March 31, 2023, the Company continued to experience a decline in its stock price resulting in the total market value of its common stock outstanding ("market capitalization") being less than the carrying value of the reporting unit. Management believes this decline in market value is due to a variety of factors, as further described below. In light of the circumstances and indicators of potential impairment described above, management performed an interim quantitative goodwill impairment test as of March 31, 2023. Management first considered whether any impairment was present for the Company’s long-lived assets, concluding that no such impairments were present after conducting an undiscounted cash flow recoverability test, except for in the Massachusetts market as detailed above. In comparing the estimated fair value of the reporting unit to its carrying value, the Company utilized a weighted average valuation using the discounted cash flow model and the market approach. The results of the Company’s interim test for impairment as of March 31, 2023 concluded that the estimated fair value of the reporting unit exceeded the carrying value, resulting in no impairment. During the three months ended June 30, 2023, the Company continued to experience a declined stock price resulting in the market capitalization being less than the carrying value of the reporting unit. The Company updated the March 31, 2023 valuation, as of June 30, 2023, with no impairment identified finding all inputs, including but not limited to future operating performance, gross margins, probability of achieving cash flows, and multiples of comparable public companies, either maintained consistency or trended positively for the three months ended June 30, 2023. Furthermore, the Company performed a sensitivity test on the income approach updating for the exit of the Massachusetts operations identifying the Massachusetts exit accretive to earnings as the Massachusetts assets were underperforming. However, the Company concluded the sustained stock price decline was a triggering event to perform an interim quantitative goodwill impairment test, as of June 30, 2023, specific to the stock price decline and resulting market capitalization of the Company. As the sole risk to the value of goodwill was the stock price, the Company concluded it most appropriate to transition to a market approach. The results of the Company’s interim test for impairment as of June 30, 2023, utilizing a market approach, indicated that the reporting unit's fair value fell below the carrying value. Based on the results of the goodwill impairment procedures, the Company recorded a $307.6 million goodwill impairment for the single reporting unit during the three months ended June 30, 2023. The Company found the June 30, 2023 goodwill impairment to be a result of the cannabis equity market including the reduced number of custodians to service cannabis equity holdings, negative investor sentiment due to lack of progress on federal reform, and more challenging macroeconomic conditions driving lower cannabis stock prices as of June 30, 2023. The Company finds this is not a negative indicator of historic or current operating results and not a negative indicator of anticipated future performance as the Company has taken steps to shed underperforming assets while focusing on cash conservation which is reflective in the results of operations as of June 30, 2023. Additionally, the resulting non-cash charge has no impact on the Company’s compliance with debt covenants, its cash flows, or available liquidity. As of September 30, 2023, the Company did not identify any events or changes in circumstances providing indication of impairment.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Schedule Of Fair Value Of Financial Instruments By Class	The fair values of financial instruments by class are as follows as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (in thousands) Financial Assets: Money market funds (1) $ 164,405 $ — $ — $ 164,405 $ 340 $ — $ — $ 340 Financial Liabilities: Interest rate swap (2) $ — $ 365 $ — $ 365 $ — $ 2,536 $ — $ 2,536 Warrant liabilities (3) $ — $ — $ — $ — $ — $ 252 $ — $ 252 There have been no transfers between hierarchy levels during the periods ending September 30, 2023 or December 31, 2022. (1) Money market funds are included within cash and cash equivalents and restricted cash in the Company’s condensed consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that approximate fair value. The Company recorded interest income of $1.6 million and $3.4 million during the three and nine months ended September 30, 2023 in relation to money market funds. Interest income for the three and nine months ended September 30, 2022 was nominal. Interest income is recorded to other income net, on the condensed consolidated statements of operations. (2) The fair value of the interest rate swap liability is recorded in other long-term liabilities on the condensed consolidated balance sheets. In November 2022 the Company entered into an interest rate swap contract ("VNB Swap") for the purpose of hedging the variability of interest expense and interest payments on the Company's long-term variable debt. The VNB Swap is carried at fair value which is based on a valuation model that utilizes interest rate yield curves and credit spreads observable in active markets as the significant inputs to the model. The Company considers credit risk associated with its own standing as well as the credit standing of any counterparties involved in the valuation of its financial instruments.

Accounts Receivable (Tables)

Accounts Receivable (Tables)	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Schedule of Accounts Receivable	Accounts receivable consisted of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Trade receivables $ 9,979 $ 8,482 Less: allowance for credit losses (3,093) (1,975) Accounts receivable, net $ 6,886 $ 6,507 Notes receivable consisted of the following as of September 30, 2023 and December 31, 2022: September 30, December 31, Stated Interest Rate Maturity Date (in thousands) Promissory note acquired in October 2021 (1) $ 7,665 $ 8,205 7.50 % 11/9/2025 Promissory note dated November 15, 2021 (2) 4,949 4,602 9.75 % 11/14/2024 Promissory note dated July 11, 2023 (1) 550 — 10.00 % 7/14/2025 Notes receivable 13,164 12,807 Less: discount on notes receivable (56) (87) Total notes receivable, net of discount 13,108 12,720 Less: current portion of notes receivable (1,069) (728) Notes receivable, net $ 12,039 $ 11,992 (1) Interest and principal payments are due to the Company monthly.

Notes Receivable (Tables)

Notes Receivable (Tables)	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Schedule of Notes Receivable	Accounts receivable consisted of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Trade receivables $ 9,979 $ 8,482 Less: allowance for credit losses (3,093) (1,975) Accounts receivable, net $ 6,886 $ 6,507 Notes receivable consisted of the following as of September 30, 2023 and December 31, 2022: September 30, December 31, Stated Interest Rate Maturity Date (in thousands) Promissory note acquired in October 2021 (1) $ 7,665 $ 8,205 7.50 % 11/9/2025 Promissory note dated November 15, 2021 (2) 4,949 4,602 9.75 % 11/14/2024 Promissory note dated July 11, 2023 (1) 550 — 10.00 % 7/14/2025 Notes receivable 13,164 12,807 Less: discount on notes receivable (56) (87) Total notes receivable, net of discount 13,108 12,720 Less: current portion of notes receivable (1,069) (728) Notes receivable, net $ 12,039 $ 11,992 (1) Interest and principal payments are due to the Company monthly.
Schedule of Stated Maturities of Notes Receivable	Stated maturities of the notes receivable are as follows as of September 30, 2023: Year Expected principal payments (in thousands) Remainder of 2023 $ 263 2024 6,033 2025 6,868 2026 — 2027 — Thereafter — Total 13,164 Less: discount on notes receivable (56) Total $ 13,108

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
Summary of Inventories	Inventories are comprised of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Raw material Cannabis plants $ 17,161 $ 21,523 Packaging and supplies 40,896 49,650 Total raw material 58,057 71,173 Work in process 117,399 158,448 Finished goods-unmedicated 5,969 7,323 Finished goods-medicated 48,472 39,561 Total inventories $ 229,897 $ 276,505

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	As of September 30, 2023 and December 31, 2022, property and equipment consisted of the following: September 30, 2023 December 31, 2022 (in thousands) Land $ 30,835 $ 38,485 Buildings and improvements 519,405 497,493 Furniture and equipment 289,796 277,164 Vehicles 838 839 Total 840,874 813,981 Less: accumulated depreciation (181,120) (125,866) Total property and equipment 659,754 688,115 Construction in progress 27,824 55,145 Total property and equipment, net $ 687,578 $ 743,260
Schedule of Expenses Related to Property, Plant and Equipment	The Company incurred the following expense related to property and equipment during the three and nine months ended September 30, 2023: Three Months Ended September 30, Nine Months Ended September 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Capitalized interest Interest expense $ 909 $ (1,366) $ 114 $ (4,006) Depreciation expense Cost of goods sold and Depreciation and amortization 18,684 18,820 57,015 51,596 Total $ 19,593 $ 17,454 $ 57,129 $ 47,590 Three Months Ended September 30, Nine Months Ended September 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Loss on impairment Impairments and disposals of long-lived assets, net $ — $ 296 $ 2,712 $ 626 Loss on disposal Impairments and disposals of long-lived assets, net 802 46,064 4,469 54,031 Total $ 802 $ 46,360 $ 7,181 $ 54,657

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	The Company's definite-lived intangible assets consisted of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value (in thousands) (in thousands) Licenses $ 1,046,544 $ 141,635 $ 904,909 $ 1,044,161 $ 89,367 $ 954,794 Trademarks 27,430 16,418 11,012 27,430 12,530 14,900 Internal use software 24,226 6,260 17,966 16,528 3,065 13,463 Tradenames 4,861 4,321 540 4,862 3,506 1,356 Customer relationships 3,535 3,402 133 3,536 3,252 284 Total $ 1,106,596 $ 172,036 $ 934,560 $ 1,096,517 $ 111,720 $ 984,797
Summary of Estimated Future Annual Amortization Expense Related to Intangible Assets	The following table outlines the estimated future amortization expense related to intangible assets as of September 30, 2023: Year Estimated (in thousands) Remainder of 2023 $ 20,375 2024 80,601 2025 77,390 2026 74,669 2027 72,166 Thereafter 609,359 $ 934,560

Held for Sale (Tables)

Held for Sale (Tables)	9 Months Ended
	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Summary of Held for Sale Assets	As of December 31, 2022, the Company had $14.5 million in assets held for sale which primarily consisted of property and equipment. (in thousands) Held for sale assets as of December 31, 2022 $ 14,521 Assets moved to held for sale 18,683 Non-cash settlement (2,481) Impairments (2,611) Assets sold (5,968) Held for sale assets as of September 30, 2023 $ 22,144 Held for sale liabilities as of December 31, 2022 $ — Liabilities moved to held for sale (1,997) Liabilities settled associated with held for sale assets 1,997 Held for sale liabilities as of September 30, 2023 $ —

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Notes Payable	As of September 30, 2023 and December 31, 2022, notes payable consisted of the following: September 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Maturity Date Net Book Value of (in thousands) Promissory notes dated December 21, 2022 (1) $ 70,454 $ 71,500 7.53% (4) 7.86% 1/1/2028 $ 154,306 Promissory note dated December 22, 2022 (2) 18,582 18,900 7.30% (4) 7.38% 12/22/2032 $ 9,193 Promissory notes dated October 1, 2021 (3) 5,751 6,095 8.14% (4) 8.29% 10/1/2027 $ 11,860 Promissory note dated December 22, 2022 5,500 5,500 10.00% (4) 10.00% 12/22/2023 (5) Promissory notes acquired in October 2021 1,743 5,338 (6) (4) (6) (6) (6) Promissory note of consolidated variable-interest entity dated February 1, 2022 982 1,200 8.00% (4) 8.00% 12/31/2025 — Total notes payable 103,012 108,533 Less: debt discount (1,586) (1,833) Less: current portion of notes payable (9,117) (12,453) Notes payable, net (7) $ 92,309 $ 94,247 (1) In connection with the closing of these four promissory notes, the Company entered into an interest rate swap to fix the interest rate at 7.53% for the term of the notes. See Note 23 in the 2022 Form 10-K for further details. These promissory notes contain customary restrictive covenants pertaining to our management and operations, including, among other things, limitations on the amount of debt that may be incurred and the ability to pledge assets, among other things, as well as financial covenant requirements, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, debt service coverage ratio, and liquidity covenant test. The covenants commence on September 30, 2023 and are measured semi-annually, except for certain covenants which were measured starting as of December 31, 2022. In May 2023, the Company amended the terms of the agreement in respect to the covenant requirements, excluding balloon payments from certain covenant calculations. (2) Promissory note bears interest at 7.30% per annum until December 21, 2027. Thereafter, interest will accrue at a rate equal to the five-year treasury rate in effect as of December 12, 2027 plus 3.50%. The promissory note contains customary restrictive covenants pertaining to our operations, including, among other things, limitations on the amount of debt and subsidiary debt that may be incurred and the ability to pledge assets, as well as financial covenant requirements, among other things, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, covenant to liquidity and debt principal test, and a global debt service coverage ratio. (3) On November 15, 2022, the Company closed on the refinancing of our promissory notes dated October 1, 2021 to extend the maturity date by five years and fix the interest rate at 8.14%. During the three months ended March 31, 2023, the Company reclassified the collateralized assets to held for sale as part of its continued efforts to optimize our assets and resources in the markets the Company serves. The Company expects to sell the assets, which primarily consist of property and equipment, within the near-term. (4) Interest payments are due monthly. (5) Promissory note is secured by the acquired membership interest in Formula 420 Cannabis LLC. See Note 4 in the 2022 Form 10-K fo r further details . (6) Seven promissory notes were acquired during the year ending December 31, 2021. Interest rates range from 0.00% to 7.00%, with a weighted average interest rate of 6.28% as of September 30, 2023. Maturity dates range from October 2023 to April 2026. Of the seven acquired promissory notes, three remain outstanding as of September 30, 2023. The three notes are secured by various assets that approximate the value of the underlying notes of $1.7 million as of September 30, 2023. (7) In addition to the notes payable listed in the above table, the Company entered into a letter of credit in October 2022 for up to $1.5 million, for which there have been no draws as of September 30, 2023. The letter of credit was payable on demand, had an interest rate of 6.25%, and expired undrawn in October 2023.
Schedule of Stated Maturities of Notes Payable	As of September 30, 2023, stated maturities of notes payable are as follows: (in thousands) Remainder of Current year end $ 7,158 2024 3,232 2025 3,825 2026 3,044 2027 69,352 Thereafter 16,401 Total $ 103,012

Private Placement Notes (Tables

Private Placement Notes (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Private Placement Notes Payable	As of September 30, 2023 and December 31, 2022, private placement notes payable consisted of the following: September 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Rate Maturity Date (in thousands) 2026 Notes - Tranche One $ 293,000 $ 350,000 8.00% 8.52% 10/6/2026 2026 Notes - Tranche Two 75,000 75,000 8.00% 8.43% 10/6/2026 June Notes 70,000 70,000 9.75% 13.32% 6/11/2024 November Notes 60,000 60,000 9.75% 13.43% 6/11/2024 Total private placement notes 498,000 555,000 Less: Unamortized debt discount and issuance costs (8,263) (13,336) Less: current portion of private placement notes, net (126,908) — Private placement notes, net $ 362,829 $ 541,664
Summary of Scheduled Maturities of Principal Portion of Private Placement Notes, Outstanding	Stated maturities of the principal portion of private placement notes outstanding as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ — 2024 130,000 2025 — 2026 368,000 2027 — Thereafter — Total private placement notes $ 498,000

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Components of Lease Cost	The following table provides the components of lease cost recognized within the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022: Three Months Ended Nine Months Ended September 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Operating lease cost Cost of goods sold, sales and marketing, general and administrative $ 5,109 $ 5,391 $ 15,249 $ 16,310 Finance lease cost: Amortization of lease assets Cost of goods sold and Depreciation and amortization 2,527 2,942 7,886 7,928 Interest on lease liabilities Interest expense 1,632 1,693 4,854 4,749 Finance lease cost 4,159 4,635 12,740 12,677 Variable lease cost Cost of goods sold, sales and marketing, general and administrative 1,897 1,816 6,613 5,591 Short term lease expense Cost of goods sold, sales and marketing, general and administrative 37 201 406 456 Total lease cost $ 11,202 $ 12,043 $ 35,008 $ 35,034
Schedule of Other Information Related to Operating and Finance Leases	Other information related to operating and finance leases is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 4,612 $ 5,401 $ 14,616 $ 15,511 Operating cash flows from finance leases $ 1,621 $ 1,695 $ 4,888 $ 4,742 Financing cash flows from finance leases $ 1,751 $ 1,925 $ 5,423 $ 4,999 ASC 842 lease additions and modifications: Operating leases $ 706 $ 2,707 $ 11,714 $ 14,677 Finance leases $ 901 $ — $ 1,018 $ 18,413 September 30, 2023 December 31, 2022 Weighted average discount rate: Operating leases 10.08 % 9.29 % Finance leases 9.23 % 8.66 % Weighted average remaining lease term (in years): Operating leases 9.1 8.3 Finance leases 7.6 7.8
Schedule of Future Minimum Lease Payments under Non-cancellable Leases	Future minimum lease payments under the Company's non-cancellable leases as of September 30, 2023 are as follows: Operating Leases Finance Leases (in thousands) Remainder of 2023 $ 4,636 $ 3,416 2024 19,236 13,811 2025 19,185 13,588 2026 18,481 12,789 2027 17,831 11,895 Thereafter 73,277 44,743 Total undiscounted lease liabilities 152,646 100,242 Less: Interest (50,338) (29,063) Total present value of minimum lease payments 102,308 71,179 Lease liabilities- current portion (9,697) (7,537) Lease liabilities $ 92,611 $ 63,642

Construction Finance Liabilit_2

Construction Finance Liabilities (Tables)	9 Months Ended
	Sep. 30, 2023
Construction Finance Liability [Abstract]
Schedule of Future Minimum Lease Payments for Construction Finance Liabilities	Future minimum lease payments for the construction finance liabilities as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ 4,186 2024 17,043 2025 17,521 2026 18,013 2027 18,519 Thereafter 302,424 Total future payments 377,706 Less: Interest (239,490) Total present value of minimum payments 138,216 Construction finance liabilities - current portion (1,393) Construction finance liabilities $ 136,823 Future minimum lease payments for the construction finance liability as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ 1,347 2024 5,455 2025 5,619 2026 5,788 2027 5,961 Thereafter 18,427 Total future payments 42,597 Less: Interest (15,983) Total present value of minimum payments 26,614 Construction finance liability - current portion (1,897) Construction finance liability $ 24,717

Share Based Compensation (Table

Share Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of Fair Value of Options Granted, Fair Value Assumptions	In determining the amount of share-based compensation related to options issued during the three months ending September 30, 2023, the Company used the Black-Scholes pricing model to establish the fair value of the options granted with the following assumptions: For the Three Months Ended September 30, 2023 Stock price at grant date $3.99 Exercise price at grant date $3.99 Expected life in years 3.30 - 3.97 Expected volatility 60.07 % - 60.85% Expected annual rate of dividends 0.00% Risk free annual interest rate 4.34 % - 4.53%
Schedule of Share-Based Compensation Expense	The Company recorded share-based compensation for stock options as follows: Three Months Ended September 30, Nine Months Ended September 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 19 $ 90 $ 54 $ 138 General and administrative 1,766 1,756 2,235 6,179 Sales and marketing 13 77 46 350 Total share-based compensation expense $ 1,798 $ 1,923 $ 2,335 $ 6,667
Schedule of Stock Option Activity	The number and weighted-average exercise prices and remaining contractual life of options as of September 30, 2023 were as follows: Number of options Weighted average exercise price Weighted average grant-date fair value Weighted average remaining contractual life (Yrs.) Aggregate intrinsic value Outstanding, January 1, 2023 3,177,815 $ 25.96 5.41 $ — Granted 1,754,817 — $ 1.98 Exercised — — Forfeited (400,388) 29.33 Outstanding, September 30, 2023 4,532,244 $ 17.15 5.12 $ — Exercisable, September 30, 2023 2,332,221 $ 24.24 3.59 $ —
Schedule of Restricted Stock Units Activity	The following is a summary of RSU activity for the nine months ended September 30, 2023 Number of Weighted average Unvested balance as of January 1, 2023 720,707 $ 22.36 Granted 2,955,177 3.99 Vested (80,521) 3.99 Forfeited (309,132) 11.21 Unvested balance as of September 30, 2023 3,286,231 $ 7.34 The Company recorded share-based compensation for RSUs as follows: Three Months Ended September 30, Nine Months Ended September 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 231 $ 302 $ 491 $ 761 General and administrative 2,284 2,011 4,204 6,463 Sales and marketing 226 56 385 668 Total share-based compensation expense $ 2,741 $ 2,369 $ 5,080 $ 7,892

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Reconciliation For Calculation of Basic And Diluted Earnings Per Share	The following is a reconciliation for the calculation of basic and diluted earnings per share: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator (in thousands, except share and per share amounts) Continuing operations Net loss from continuing operations $ (22,916) $ (72,626) $ (399,292) $ (118,397) Less: Net loss attributable to non-controlling interest (451) (518) (3,788) (2,555) Net loss from continuing operations available to common shareholders of Trulieve Cannabis Corp. $ (22,465) $ (72,108) $ (395,504) $ (115,842) Discontinued operations Net loss from discontinued operations $ (2,927) $ (42,446) $ (99,054) $ (53,178) Less: Net loss attributable to non-controlling interest — — (1,193) — Net loss from discontinued operations excluding non-controlling interest $ (2,927) $ (42,446) $ (97,861) $ (53,178) Denominator Weighted average number of common shares outstanding - Basic and diluted 188,924,694 188,597,094 188,959,454 187,549,359 Loss per Share - Continuing operations Basic and diluted loss per share $ (0.12) $ (0.38) $ (2.09) $ (0.63) Loss per Share - Discontinued operations Basic and diluted loss per share $ (0.02) $ (0.23) $ (0.52) $ (0.28)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Shares which have been excluded from diluted per share amounts because their effect would have been anti-dilutive are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Stock options 4,532,244 3,289,663 3,500,810 3,461,280 Restricted share units 3,286,231 901,689 1,532,393 1,005,259 Warrants 9,496 767,499 65,461 1,723,676

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Summary of Income Tax Expense and Effective Tax Rate	The following table summarizes the Company’s income tax expense and effective tax rate for the three and nine months ended September 30, 2023 and 2022. Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Income (loss) before provision for income taxes $13,724 $(44,256) $(293,359) $(1,627) Provision for income taxes $36,640 $28,370 $105,933 $116,770 Effective tax rate 267% (64%) (36%) (7177%)
Schedule of Unrecognized Tax Benefits Roll Forward	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: September 30, 2023 (in thousands) Balance as of January 1, 2023 $ 41,781 Additions based on tax positions related to the prior year 321,748 Additions based on tax positions related to the current year 107,013 Ending Balance as of September 30, 2023 $ 470,542

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Summary of Assets and Liabilities, Loss from Discontinued Operations and Cash Flow Including Continuing from Discontinued Operations	The assets and liabilities associated with discontinued operations consisted of the following as September 30, 2023 and December 31, 2022: September 30, 2023 December 31, 2022 (in thousands) Assets associated with discontinued operations Cash $ 94 $ 5,702 Accounts receivable, net 2,686 2,936 Inventories — 21,310 Income tax receivable 2,554 2,299 Prepaids expenses and other current assets 880 1,486 Deferred tax asset — 766 Property and equipment, net — 53,687 Right of use assets - operating, net — 2,453 Right of use assets - finance, net — 5,736 Intangible assets, net — 27,849 Other assets 2,010 2,638 Total assets associated with discontinued operations $ 8,224 $ 126,862 Liabilities associated with discontinued operations Accounts payable and accrued liabilities $ 870 $ 1,617 Deferred revenue — 109 Operating lease liabilities - current portion 158 146 Finance lease liabilities - current portion 343 456 Construction finance liability - current portion 1,897 — Operating lease liabilities 15,366 17,108 Finance lease liabilities 2,527 5,890 Construction finance liability 24,717 45,217 Other long-term liabilities 6 155 Total liabilities associated with discontinued operations $ 45,884 $ 70,698 The following table summarizes the Company's loss from discontinued operations for the three and nine months ended September 30, 2023 and 2022. The gain and loss resulting from the forgiveness of intercompany payables has been eliminated in consolidation. Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Revenue $ 2,332 $ 6,031 $ 10,679 $ 20,262 Cost of goods sold 2,812 8,006 29,843 25,238 Gross margin (480) (1,975) (19,164) (4,976) Expenses: Operating expenses 916 3,051 5,298 9,100 Impairment and disposal of long-lived assets, net 565 49,069 69,840 49,069 Total Expenses 1,481 52,120 75,138 58,169 Loss from operations (1,961) (54,095) (94,302) (63,145) Other (expense) income: Interest expense, net (971) (1,533) (4,149) (4,590) Other income, net — 30 22 90 Total other expense, net (971) (1,503) (4,127) (4,500) Loss before provision for income taxes (2,932) (55,598) (98,429) (67,645) Income tax (provision) benefit 5 13,152 (625) 14,467 Net loss from discontinued operations, net of tax (provision) benefit (2,927) (42,446) (99,054) (53,178) Less: Net loss attributable to non-controlling interest from discontinued operations — — (1,193) — Net loss from discontinued operations excluding non-controlling interest $ (2,927) $ (42,446) $ (97,861) $ (53,178) Nine Months Ended September 30, 2023 2022 Depreciation and amortization $ 3,798 $ 8,707 Purchases of property plant and equipment $ 67 $ 799 Loss on impairment of long-lived assets $ 69,840 $ 49,069 Other noncash investing and financing activities Noncash partial extinguishment of construction finance liability $ 18,486 $ —
Schedule of Future minimum Lease Payments for Construction Finance Liability	Future minimum lease payments for the construction finance liabilities as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ 4,186 2024 17,043 2025 17,521 2026 18,013 2027 18,519 Thereafter 302,424 Total future payments 377,706 Less: Interest (239,490) Total present value of minimum payments 138,216 Construction finance liabilities - current portion (1,393) Construction finance liabilities $ 136,823 Future minimum lease payments for the construction finance liability as of September 30, 2023, are as follows: Year (in thousands) Remainder of 2023 $ 1,347 2024 5,455 2025 5,619 2026 5,788 2027 5,961 Thereafter 18,427 Total future payments 42,597 Less: Interest (15,983) Total present value of minimum payments 26,614 Construction finance liability - current portion (1,897) Construction finance liability $ 24,717

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Assets and Liabilities of Company's VIEs	The following table presents the summarized assets and liabilities of the Company’s VIEs in which the Company does not hold a majority interest as of September 30, 2023 and December 31, 2022. The assets and liabilities in the table below include third-party assets and liabilities of our VIEs only and exclude intercompany balances that eliminate in consolidation as included on our condensed consolidated balance sheets. September 30, 2023 December 31, 2022 (in thousands) Current assets: Cash $ 7,335 $ 7,349 Accounts receivable, net 1,386 597 Inventories 8,730 7,590 Prepaid expenses and other current assets 641 46 Total current assets 18,092 15,582 Property and equipment, net 28,248 25,994 Right of use asset - operating, net 2,781 — Right of use asset - finance, net 278 224 Intangible assets, net 17,496 17,947 Other assets 147 344 Total assets $ 67,042 $ 60,091 Current liabilities: Accounts payable and accrued liabilities $ 2,308 $ 3,713 Income tax payable 2,538 1,615 Deferred revenue 2 6 Operating lease liability - current portion 44 — Finance lease liability - current portion 59 41 Total current liabilities 4,951 5,375 Notes payable 982 1,200 Operating lease liability 2,961 — Finance lease liability 227 185 Deferred tax liabilities 3,663 4,101 Other long-term liabilities 670 625 Total liabilities $ 13,454 $ 11,486

Related Parties (Tables)

Related Parties (Tables)	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Right of Use Assets and Lease Liabilities under ASC 842	As of September 30, 2023, and December 31, 2022, under ASC 842, the Company had the following related party operating leases on the condensed consolidated balance sheets: As of September 30, 2023 As of December 31, 2022 (in thousands) Right-of-use assets, net $ 736 $ 820 Lease liabilities: Lease liabilities - current portion $ 123 $ 113 Lease liabilities 658 751 Total related parties lease liabilities $ 781 $ 864

Revenue Disaggregation (Tables)

Revenue Disaggregation (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Net Revenues Comprised	Net revenues are comprised of the following for the three and nine months ended September 30, 2023 and 2022: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (in thousands) Retail $ 263,166 $ 282,765 $ 809,899 $ 870,410 Wholesale, licensing, and other 12,044 12,588 32,320 49,343 Revenue $ 275,210 $ 295,353 $ 842,219 $ 919,753

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) segment unit	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reduction in accrual of revenue due to termination of loyalty program			$ 4,700
Loyalty liability	$ 3,000				$ 3,000		$ 8,900
Customer credit balance in deferred revenue	600				600		$ 500
Impairments and disposals of long-lived assets, net	(1,209)			$ 54,639	$ 5,480	$ 76,155
Number of operating segment | segment					1
Number of reporting unit | unit					1
Impairment of goodwill	$ 0	$ 307,600		$ 0	$ 307,590	$ 0
Property and Equipment and Intangible Assets
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairments and disposals of long-lived assets, net			30,300
Discontinued Operations | Property and Equipment and Intangible Assets
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairments and disposals of long-lived assets, net			27,600
Continuing Operations | Property and Equipment and Intangible Assets
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairments and disposals of long-lived assets, net			$ 2,700

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule Of Fair Value Of Financial Instruments By Class (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value liabilities transfers amount		$ 0	$ 0
Interest income	$ 1,600	3,400
Money Market Funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	164,405	164,405	340
Money Market Funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	164,405	164,405	340
Money Market Funds | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	0	0	0
Money Market Funds | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure	0	0	0
Interest Rate Swap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	365	365	2,536
Interest Rate Swap | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	0	0	0
Interest Rate Swap | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	365	365	2,536
Interest Rate Swap | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	0	0	0
Warrant Liability
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	0	0	252
Warrant Liability | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	0	0	0
Warrant Liability | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	0	0	252
Warrant Liability | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	$ 0	$ 0	$ 0

Accounts Receivable - Schedule

Accounts Receivable - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Trade receivables	$ 9,979	$ 8,482
Less: allowance for credit losses	(3,093)	(1,975)
Accounts receivable, net	$ 6,886	$ 6,507

Notes Receivable - Schedule of

Notes Receivable - Schedule of Notes Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 13,164	$ 12,807
Less: discount on notes receivable	(56)	(87)
Total notes receivable, net of discount	13,108	12,720
Less: current portion of notes receivable	(1,069)	(728)
Notes receivable, net	$ 12,039	11,992
Effective interest rate (as a percent)	10.77%
Promissory Note Acquired in October 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 7,665	$ 8,205
Stated Interest Rate	7.50%	7.50%
Promissory Note Dated November 15, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 4,949	$ 4,602
Stated Interest Rate	9.75%	9.75%
Promissory Note Dated July 11, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 550	$ 0
Stated Interest Rate	10%	10%

Notes Receivable - Additional I

Notes Receivable - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Other income
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 0.3	$ 0.3	$ 0.9	$ 1

Notes Receivable - Schedule o_2

Notes Receivable - Schedule of Stated Maturities of Notes Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Remainder of 2023	$ 263
2024	6,033
2025	6,868
2026	0
2027	0
Thereafter	0
Total	13,164	$ 12,807
Less: discount on notes receivable	(56)	(87)
Total notes receivable, net of discount	$ 13,108	$ 12,720

Inventories - Summary of Invent

Inventories - Summary of Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Inventory [Line Items]
Total raw material	$ 58,057	$ 71,173
Work in process	117,399	158,448
Total inventories	229,897	276,505
Cannabis plants
Inventory [Line Items]
Total raw material	17,161	21,523
Packaging and supplies
Inventory [Line Items]
Total raw material	40,896	49,650
Finished goods-unmedicated
Inventory [Line Items]
Finished goods - unmedicated and medicated	5,969	7,323
Finished goods-medicated
Inventory [Line Items]
Finished goods - unmedicated and medicated	$ 48,472	$ 39,561

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Total	$ 840,874	$ 813,981
Less: accumulated depreciation	(181,120)	(125,866)
Total property and equipment	659,754	688,115
Total property and equipment, net	687,578	743,260
Land
Property Plant And Equipment [Line Items]
Total	30,835	38,485
Buildings and Improvements
Property Plant And Equipment [Line Items]
Total	519,405	497,493
Furniture and Equipment
Property Plant And Equipment [Line Items]
Total	289,796	277,164
Vehicles
Property Plant And Equipment [Line Items]
Total	838	839
Construction In Progress
Property Plant And Equipment [Line Items]
Construction in progress	$ 27,824	$ 55,145

Property and Equipment - Sche_2

Property and Equipment - Schedule of Expenses Related to Property, Plant and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property Plant And Equipment [Line Items]
Capitalized interest	$ 909	$ (1,366)	$ 114	$ (4,006)
Cost of goods sold and Depreciation and amortization	18,684	18,820	57,015	51,596
Total	19,593	17,454	57,129	47,590
Impairments and disposals of long-lived assets, net	0	296	2,712	626
Impairments and disposals of long-lived assets, net
Property Plant And Equipment [Line Items]
Loss on disposal of long-lived assets	802	46,064	4,469	54,031
Loss on impairment and disposal of property and equipment	$ 802	$ 46,360	$ 7,181	$ 54,657

Intangible Assets - Summary of

Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,106,596	$ 1,096,517
Accumulated Amortization	172,036	111,720
Net Book Value	934,560	984,797
Licenses
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,046,544	1,044,161
Accumulated Amortization	141,635	89,367
Net Book Value	904,909	954,794
Trademarks
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	27,430	27,430
Accumulated Amortization	16,418	12,530
Net Book Value	11,012	14,900
Internal use software
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	24,226	16,528
Accumulated Amortization	6,260	3,065
Net Book Value	17,966	13,463
Tradenames
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	4,861	4,862
Accumulated Amortization	4,321	3,506
Net Book Value	540	1,356
Customer relationships
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,535	3,536
Accumulated Amortization	3,402	3,252
Net Book Value	$ 133	$ 284

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 20.2	$ 20.9	$ 60.3	$ 62
Gain on sale of intangible assets			$ 3
Weighted average amortization period remaining for intangible assets (in years)	12 years 8 months 12 days		12 years 8 months 12 days

Intangible Assets - Summary o_2

Intangible Assets - Summary of Estimated Future Annual Amortization Expense Related to Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 20,375
2024	80,601
2025	77,390
2026	74,669
2027	72,166
Thereafter	609,359
Net Book Value	$ 934,560	$ 984,797

Held for Sale - Additional Info

Held for Sale - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on impairment charges for disposal of held for sale assets	$ 1,000	$ 2,500	$ 3,600	$ 5,100
Disposal Group, Held-for-Sale, Not Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	22,144		22,144		$ 14,521
Prepaid Expenses and Other Current Assets | Disposal Group, Held-for-Sale, Not Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	$ 22,100		$ 22,100		$ 14,500

Held for Sale - Summary of Held

Held for Sale - Summary of Held for Sale Assets (Details) - Disposal Group, Held-for-Sale, Not Discontinued Operations $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Held for sale assets, Beginning balance	$ 14,521
Assets moved to held for sale	18,683
Non-cash settlement	(2,481)
Impairments	(2,611)
Assets sold	(5,968)
Held for sale assets, Ending balance	22,144
Held for sale liabilities, Beginning balance	0
Liabilities moved to held for sale	(1,997)
Liabilities settled associated with held for sale assets	1,997
Held for sale liabilities, Ending balance	$ 0

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable, Net (Details) $ in Thousands		1 Months Ended	9 Months Ended	12 Months Ended
	Nov. 15, 2022	Oct. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) note	Dec. 31, 2021 note	Dec. 31, 2022 USD ($)
Notes Payable [Line Items]
Total notes payable			$ 103,012		$ 108,533
Less: debt discount, current			(1,586)		(1,833)
Less: current portion of notes payable			(9,117)		(12,453)
Notes payable, net			$ 92,309		94,247
Effective interest rate (as a percent)			10.77%
Letter of credit		$ 1,500
Letter of credit interest rate		6.25%
Promissory notes dated December 21, 2022
Notes Payable [Line Items]
Total notes payable			$ 70,454		71,500
Stated Interest Rate			7.53%
Effective interest rate (as a percent)			7.86%
Net Book Value of Collateral			$ 154,306
Number of promissory notes, closed | note			4
Promissory note dated December 22, 2022
Notes Payable [Line Items]
Total notes payable			$ 18,582		18,900
Stated Interest Rate			7.30%
Effective interest rate (as a percent)			7.38%
Net Book Value of Collateral			$ 9,193
Promissory note dated December 22, 2022 | Five-year treasury rate
Notes Payable [Line Items]
Basis spread on variable rate			3.50%
Promissory notes dated October 1, 2021
Notes Payable [Line Items]
Total notes payable			$ 5,751		6,095
Stated Interest Rate	8.14%		8.14%
Effective interest rate (as a percent)			8.29%
Net Book Value of Collateral			$ 11,860
Refinancing debt instrument term	5 years
Promissory note dated December 22, 2022
Notes Payable [Line Items]
Total notes payable			$ 5,500		5,500
Stated Interest Rate			10%
Effective interest rate (as a percent)			10%
Promissory notes acquired in Harvest Acquisition
Notes Payable [Line Items]
Total notes payable			$ 1,743		5,338
Number of promissory notes, acquired | note				7
Number of remaining outstanding promissory notes | note			3
Promissory notes, secured of underlying notes			$ 1,700
Promissory notes acquired in Harvest Acquisition | Minimum
Notes Payable [Line Items]
Stated Interest Rate			0%
Promissory notes acquired in Harvest Acquisition | Maximum
Notes Payable [Line Items]
Stated Interest Rate			7%
Promissory notes acquired in Harvest Acquisition | Weighted Average
Notes Payable [Line Items]
Stated Interest Rate			6.28%
Promissory note of consolidated variable-interest entity dated February 1, 2022
Notes Payable [Line Items]
Total notes payable			$ 982		$ 1,200
Stated Interest Rate			8%
Effective interest rate (as a percent)			8%

Notes Payable - Additional Info

Notes Payable - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Debt Disclosure [Abstract]
Notes payable, interest expense	$ 2.1	$ 0.2	$ 6.3	$ 0.5
Notes payable, accretion expense	$ 0.1	$ 0	$ 0.3	$ 0.1

Notes Payable - Schedule of Sta

Notes Payable - Schedule of Stated Maturities of Notes Payable (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Remainder of Current year end	$ 7,158
2024	3,232
2025	3,825
2026	3,044
2027	69,352
Thereafter	16,401
Total notes payable	$ 103,012	$ 108,533

Private Placement Notes - Addit

Private Placement Notes - Additional Information (Details)			3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 28, 2022 USD ($)	Oct. 06, 2021 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2019 USD ($) Warrant $ / shares shares
Debt Instrument [Line Items]
Gain on extinguishment of debt					$ 8,161,000	$ 0
Interest expense incurred			$ 13,200,000	$ 13,100,000	39,100,000	38,900,000
Accretion expense			$ 1,500,000	$ 1,300,000	$ 4,300,000	$ 3,800,000
June Notes
Debt Instrument [Line Items]
Debt instrument term (in years)							5 years
Debt instrument face amount							$ 70,000,000
Warrants to purchase of shares (in shares) | shares							1,470,000
Warrants exercise price (in dollars per share) | $ / shares							$ 13.47
Notes payable, annual interest rate			9.75%		9.75%
November Notes
Debt Instrument [Line Items]
Debt instrument term (in years)							5 years
Debt instrument face amount							$ 60,000,000
Warrants to purchase of shares (in shares) | shares							1,560,000
Warrants exercise price (in dollars per share) | $ / shares							$ 980
Denominations value of note issued							$ 1,000
Number of warrants in denominations | Warrant							26
Debt instrument exercised period							3 years
Notes payable, annual interest rate			9.75%		9.75%
2026 Notes - Tranche One
Debt Instrument [Line Items]
Notes payable, annual interest rate		8%	8%		8%
Gross proceeds from private placement		$ 350,000,000
Net proceeds from private placement		$ 342,600,000
Extinguishment of debt			$ 57,000,000
Discounted purchase amount (as a percent)			0.165
Payment for debt extinguishment			$ 48,000,000
Gain on extinguishment of debt			$ 8,200,000		$ 8,200,000
2026 Notes - Tranche Two
Debt Instrument [Line Items]
Notes payable, annual interest rate	8%		8%		8%
Gross proceeds from private placement	$ 76,900,000
Net proceeds from private placement	$ 75,600,000

Private Placement Notes - Sched

Private Placement Notes - Schedule of Private Placement Notes Payable (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 28, 2022	Oct. 06, 2021
Debt Instrument [Line Items]
Total private placement notes	$ 498,000	$ 555,000
Less: Unamortized debt discount and issuance costs	(8,263)	(13,336)
Less: current portion of private placement notes, net	(126,908)	0
Private placement notes, net	$ 362,829	541,664
Effective interest rate (as a percent)	10.77%
2026 Notes - Tranche One
Debt Instrument [Line Items]
Total private placement notes	$ 293,000	350,000
Stated Interest Rate	8%			8%
Effective interest rate (as a percent)	8.52%
2026 Notes - Tranche Two
Debt Instrument [Line Items]
Total private placement notes	$ 75,000	75,000
Stated Interest Rate	8%		8%
Effective interest rate (as a percent)	8.43%
June Notes
Debt Instrument [Line Items]
Total private placement notes	$ 70,000	70,000
Stated Interest Rate	9.75%
Effective interest rate (as a percent)	13.32%
November Notes
Debt Instrument [Line Items]
Total private placement notes	$ 60,000	$ 60,000
Stated Interest Rate	9.75%
Effective interest rate (as a percent)	13.43%

Private Placement Notes - Summa

Private Placement Notes - Summary of Scheduled Maturities of Principal Portion of Private Placement Notes Outstanding (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Remainder of 2023	$ 0
2024	130,000
2025	0
2026	368,000
2027	0
Thereafter	0
Total private placement notes	$ 498,000	$ 555,000

Leases - Additional Information

Leases - Additional Information (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023 USD ($) lease	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)
Lessee, Lease, Description [Line Items]
Loss on disposal of right of use assets		$ 6.1		$ 16.6
Gain on termination of lease	$ 5.9	$ 0.3	$ 5.9	$ 0.3
Number of cannabis dispensary leases | lease	2
Property Lease Guarantee
Lessee, Lease, Description [Line Items]
Lease term (in years)	6 years		6 years
Maximum exposure	$ 5.4		$ 5.4		$ 5.8
Property Lease Guarantee, Undiscounted Future Minimum Lease Payments
Lessee, Lease, Description [Line Items]
Maximum exposure					2.5
Property Lease Guarantee, Additional Payments
Lessee, Lease, Description [Line Items]
Maximum exposure					$ 3.3
Minimum | Property Lease Guarantee
Lessee, Lease, Description [Line Items]
Lease term (in years)					8 years
Maximum | Property Lease Guarantee
Lessee, Lease, Description [Line Items]
Lease term (in years)					9 years
Real Estate Assets | Minimum
Lessee, Lease, Description [Line Items]
Lease term (in years)	5 years		5 years
Real Estate Assets | Maximum
Lessee, Lease, Description [Line Items]
Lease term (in years)	10 years		10 years
Other Leased Assets | Minimum
Lessee, Lease, Description [Line Items]
Lease term (in years)	3 years		3 years
Other Leased Assets | Maximum
Lessee, Lease, Description [Line Items]
Lease term (in years)	5 years		5 years

Leases - Components of Lease Co

Leases - Components of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating lease cost	$ 5,109	$ 5,391	$ 15,249	$ 16,310
Finance lease cost:
Amortization of lease assets	2,527	2,942	7,886	7,928
Interest on lease liabilities	1,632	1,693	4,854	4,749
Finance lease cost	4,159	4,635	12,740	12,677
Variable lease cost	1,897	1,816	6,613	5,591
Short term lease expense	37	201	406	456
Total lease cost	$ 11,202	$ 12,043	$ 35,008	$ 35,034

Leases - Summary of Other Infor

Leases - Summary of Other Information Related to Operating and Finance Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 4,612	$ 5,401	$ 14,616	$ 15,511
Operating cash flows from finance leases	1,621	1,695	4,888	4,742
Financing cash flows from finance leases	1,751	1,925	5,423	4,999
ASC 842 lease additions and modifications:
Operating leases	706	2,707	11,714	14,677
Finance leases	$ 901	$ 0	$ 1,018	$ 18,413
Weighted average discount rate:
Operating leases, weighted average discount rate (as a percent)	10.08%		10.08%		9.29%
Finance leases, weighted average discount rate (as a percent)	9.23%		9.23%		8.66%
Weighted average remaining lease term (in years):
Operating leases, weighted average remaining lease term (in years)	9 years 1 month 6 days		9 years 1 month 6 days		8 years 3 months 18 days
Finance leases, weighted average remaining lease term (in years)	7 years 7 months 6 days		7 years 7 months 6 days		7 years 9 months 18 days

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments under Non-cancellable Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Operating Leases
Remainder of 2023	$ 4,636
2024	19,236
2025	19,185
2026	18,481
2027	17,831
Thereafter	73,277
Total undiscounted lease liabilities	152,646
Less: Interest	(50,338)
Total present value of minimum lease payments	102,308
Lease liabilities- current portion	(9,697)	$ (10,291)
Lease liabilities	92,611	99,851
Finance Leases
Remainder of 2023	3,416
2024	13,811
2025	13,588
2026	12,789
2027	11,895
Thereafter	44,743
Total undiscounted lease liabilities	100,242
Less: Interest	(29,063)
Total present value of minimum lease payments	71,179
Lease liabilities- current portion	(7,537)	(8,271)
Lease liabilities	$ 63,642	$ 69,948

Construction Finance Liabilit_3

Construction Finance Liabilities - Additional Information (Details) $ in Millions	1 Months Ended		3 Months Ended		9 Months Ended
	Oct. 31, 2021 USD ($) option	Oct. 31, 2019 USD ($) option	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) option	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Construction Finance Liability [Line Items]
Construction finance liability interest expense			$ 4.1	$ 4.1	$ 12.3	$ 11.8
Hancock
Construction Finance Liability [Line Items]
Construction finance liability			18.8		$ 18.8		$ 19.7
Finance lease liability, initial term	10 years
Number of options to extend finance lease | option					2
Finance lease liability, extended term	5 years
Tenant improvements allowance	$ 12.9
Tenant allowance, amount provided			12.7		$ 12.7		12.3
Florida
Construction Finance Liability [Line Items]
Proceeds from sale of property		$ 17
Construction finance liability			17.8		17.8		17.7
Pennsylvania
Construction Finance Liability [Line Items]
Construction finance liability			42.3		42.3		41.8
Finance lease liability, initial term		15 years
Number of options to extend finance lease | option		2
Finance lease liability, extended term		5 years
Alachua
Construction Finance Liability [Line Items]
Construction finance liability			$ 59.3		$ 59.3		$ 59.2
Finance lease liability, initial term	20 years
Number of options to extend finance lease | option	2
Finance lease liability, extended term	5 years
Loss on disposal of long-lived assets				$ 42.4

Construction Finance Liabilit_4

Construction Finance Liabilities - Schedule of Future minimum Lease Payments for Construction Finance Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Construction Finance Liability [Abstract]
Remainder of 2023	$ 4,186
2024	17,043
2025	17,521
2026	18,013
2027	18,519
Thereafter	302,424
Total future payments	377,706
Less: Interest	(239,490)
Total present value of minimum payments	138,216
Construction finance liabilities - current portion	(1,393)	$ (1,189)
Construction finance liabilities	$ 136,823	$ 137,144

Share Based Compensation - Addi

Share Based Compensation - Additional Information (Details) - USD ($) $ in Millions		9 Months Ended
	Jul. 25, 2023	Sep. 30, 2023
Class Of Stock [Line Items]
Share based compensation unvested options, unrecognized compensation cost		$ 3.7
Share based compensation unvested options, unrecognized compensation expense weighted average recognition period (in years)		8 months 23 days
2021 Plan
Class Of Stock [Line Items]
Shares reserved for future instances (in shares)		10,000,000
RSUs
Class Of Stock [Line Items]
Share based compensation unvested options, unrecognized compensation cost		$ 12.7
Share based compensation unvested options, unrecognized compensation expense weighted average recognition period (in years)		10 months 17 days
RSUs | Director
Class Of Stock [Line Items]
Vesting period (in years)	30 days
RSUs | Non-Director Employee
Class Of Stock [Line Items]
Vesting period (in years)	2 years

Share Based Compensation - Fair

Share Based Compensation - Fair Value of the Options, Assumptions (Details)	3 Months Ended
	Sep. 30, 2023 $ / shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock price at grant date (in dollars per share)	$ 3.99
Exercise price at grant date (in dollars per share)	$ 3.99
Expected volatility rate, minimum	60.07%
Expected volatility rate, maximum	60.85%
Expected annual rate of dividends	0%
Risk free annual interest rate, minimum	4.34%
Risk free annual interest rate, maximum	4.53%
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life in years	3 years 3 months 18 days
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life in years	3 years 11 months 19 days

Share Based Compensation - Sche

Share Based Compensation - Schedule of Share Based Compensation Arrangements by Share-Based Payment Award (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	$ 1,798	$ 1,923	$ 2,335	$ 6,667
RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	2,741	2,369	5,080	7,892
Cost of Goods Sold
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	19	90	54	138
Cost of Goods Sold | RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	231	302	491	761
General and Administrative Expenses
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	1,766	1,756	2,235	6,179
General and Administrative Expenses | RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	2,284	2,011	4,204	6,463
Sales and Marketing
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	13	77	46	350
Sales and Marketing | RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	$ 226	$ 56	$ 385	$ 668

Share Based Compensation - Sc_2

Share Based Compensation - Schedule of Stock Option Activity (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Number of options
Outstanding, beginning balance (in shares)	3,177,815
Granted (in shares)	1,754,817
Exercised (in shares)	0
Forfeited (in shares)	(400,388)
Outstanding, ending balance (in shares)	4,532,244	3,177,815
Number of options, exercisable (in shares)	2,332,221
Weighted average exercise price
Beginning balance (in dollars per share)	$ 25.96
Forfeited (in dollars per share)	29.33
Ending balance (in dollars per share)	17.15	$ 25.96
Weighted average grant-date fair value (in dollars per share)	1.98
Weighted average exercise price, exercisable (in dollars per share)	$ 24.24
Weighted Average Remaining Contractual Life, outstanding (in years)	5 years 1 month 13 days	5 years 4 months 28 days
Weighted Average Remaining Contractual Life, exercisable (in years)	3 years 7 months 2 days

Share Based Compensation - Sc_3

Share Based Compensation - Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Number of restricted stock units
Beginning balance (in shares) | shares	720,707
Granted (in shares) | shares	2,955,177
Vested (in shares) | shares	(80,521)
Forfeited (in shares) | shares	(309,132)
Ending balance (in shares) | shares	3,286,231
Weighted average grant price
Beginning balance (in dollars per share) | $ / shares	$ 22.36
Granted (in dollars per share) | $ / shares	3.99
Vested (in dollars per share) | $ / shares	3.99
Forfeited (in dollars per share) | $ / shares	11.21
Ending balance (in dollars per share) | $ / shares	$ 7.34

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Reconciliation For Calculation Of Basic And Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Net loss from continuing operations	$ (22,916)	$ (72,626)	$ (399,292)	$ (118,397)
Less: Net loss attributable to non-controlling interest	(451)	(518)	(3,788)	(2,555)
Net loss from continuing operations available to common shareholders of Trulieve Cannabis Corp.	(22,465)	(72,108)	(395,504)	(115,842)
Net loss from discontinued operations	(2,927)	(42,446)	(99,054)	(53,178)
Less: Net loss attributable to non-controlling interest	0	0	(1,193)	0
Net loss from discontinued operations excluding non-controlling interest	$ (2,927)	$ (42,446)	$ (97,861)	$ (53,178)
Weighted average number of common shares outstanding, basic (in shares)	188,924,694	188,597,094	188,959,454	187,549,359
Weighted average number of common shares outstanding, diluted (in shares)	188,924,694	188,597,094	188,959,454	187,549,359
Basic loss per share - continuing operations (in dollars per share)	$ (0.12)	$ (0.38)	$ (2.09)	$ (0.63)
Diluted loss per share - continuing operations (in dollars per share)	(0.12)	(0.38)	(2.09)	(0.63)
Basic loss per share - discontinued operations (in dollars per share)	(0.02)	(0.23)	(0.52)	(0.28)
Diluted loss per share - discontinued operations (in dollars per share)	$ (0.02)	$ (0.23)	$ (0.52)	$ (0.28)

Earnings Per Share - Schedule_2

Earnings Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share based awards (in shares)	4,532,244	3,289,663	3,500,810	3,461,280
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share based awards (in shares)	3,286,231	901,689	1,532,393	1,005,259
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share based awards (in shares)	9,496	767,499	65,461	1,723,676

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - shares	Sep. 30, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock, shares issued (in shares)	185,987,512	185,987,512
Common stock, shares outstanding (in shares)	185,987,512	185,987,512
Not Contractually Issuable Until 2024 | Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares reserved for future instances (in shares)	2,900,000
Not Contractually Issuable Until the Earlier of December 1, 2030 | Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares reserved for future instances (in shares)	100,000

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Expense and Effective Tax Rate (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income (loss) before provision for income taxes	$ 13,724	$ (44,256)	$ (293,359)	$ (1,627)
Provision for income taxes	$ 36,640	$ 28,370	$ 105,933	$ 116,770
Effective tax rate (as a percent)	267%	(64.00%)	(36.00%)	(7177.00%)

Income Taxes - Uncertain Tax Li

Income Taxes - Uncertain Tax Liabilities (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits, beginning balance	$ 41,781
Additions based on tax positions related to the prior year	321,748
Additions based on tax positions related to the current year	107,013
Unrecognized tax benefits, ending balance	$ 470,542

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Unrecognized tax benefits, income tax penalties and interest accrued	$ 81,400,000		$ 19,500,000
Increase in uncertain tax positions	62,000,000
Increase resulting from tax position, IRC Section 280E	49,400,000
Increase resulting from tax position relating to inventory costs	12,500,000
Interest on income tax expense	2,200,000	$ 300,000
Income tax penalties expense	0	$ 0
Tax payments on deposits	$ 116,600,000

Discontinued Operations - Summa

Discontinued Operations - Summary of Assets and Liabilities Associated with Discontinued Operations (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Cash	$ 100	$ 4,000	$ 14,000	$ 5,700
Massachusetts and Nevada Operations | Disposed of by Sale
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Cash	94	5,702
Accounts receivable, net	2,686	2,936
Inventories	0	21,310
Income tax receivable	2,554	2,299
Prepaids expenses and other current assets	880	1,486
Deferred tax asset	0	766
Property and equipment, net	0	53,687
Right of use assets - operating, net	0	2,453
Right of use assets - finance, net	0	5,736
Intangible assets, net	0	27,849
Other assets	2,010	2,638
Total assets associated with discontinued operations	8,224	126,862
Liabilities associated with discontinued operations
Accounts payable and accrued liabilities	870	1,617
Deferred revenue	0	109
Operating lease liabilities - current portion	158	146
Finance lease liabilities - current portion	343	456
Construction finance liability - current portion	1,897	0
Operating lease liabilities	15,366	17,108
Finance lease liabilities	2,527	5,890
Construction finance liability	24,717	45,217
Other long-term liabilities	6	155
Total liabilities associated with discontinued operations	$ 45,884	$ 70,698

Discontinued Operations - Sum_2

Discontinued Operations - Summary of Income (Loss) from Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Other (expense) income:
Income tax (provision) benefit	$ 5	$ 13,152	$ (625)	$ 14,467
Net loss from discontinued operations, net of tax (provision) benefit	(2,927)	(42,446)	(99,054)	(53,178)
Less: Net loss attributable to non-controlling interest from discontinued operations	0	0	(1,193)	0
Net loss from discontinued operations excluding non-controlling interest	(2,927)	(42,446)	(97,861)	(53,178)
Massachusetts and Nevada Operations | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	2,332	6,031	10,679	20,262
Cost of goods sold	2,812	8,006	29,843	25,238
Gross margin	(480)	(1,975)	(19,164)	(4,976)
Expenses:
Operating expenses	916	3,051	5,298	9,100
Impairment and disposal of long-lived assets, net	565	49,069	69,840	49,069
Total Expenses	1,481	52,120	75,138	58,169
Loss from operations	(1,961)	(54,095)	(94,302)	(63,145)
Other (expense) income:
Interest expense, net	(971)	(1,533)	(4,149)	(4,590)
Other income, net	0	30	22	90
Total other expense, net	(971)	(1,503)	(4,127)	(4,500)
Loss before provision for income taxes	(2,932)	(55,598)	(98,429)	(67,645)
Income tax (provision) benefit	5	13,152	(625)	14,467
Net loss from discontinued operations, net of tax (provision) benefit	(2,927)	(42,446)	(99,054)	(53,178)
Less: Net loss attributable to non-controlling interest from discontinued operations	0	0	(1,193)	0
Net loss from discontinued operations excluding non-controlling interest	$ (2,927)	$ (42,446)	$ (97,861)	$ (53,178)

Discontinued Operations - Sum_3

Discontinued Operations - Summary of Depreciation, Amortization, Loss on Impairment of Long-lived Assets, and Capital Expenditures of Discontinued Operations (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Other noncash investing and financing activities
Noncash partial extinguishment of construction finance liability	$ 18,486	$ 0
Massachusetts and Nevada Operations | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization	3,798	8,707
Purchases of property plant and equipment	67	799
Loss on impairment of long-lived assets	69,840	49,069
Other noncash investing and financing activities
Noncash partial extinguishment of construction finance liability	$ 18,486	$ 0

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Details) - Massachusetts $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (loss) on extinguishment on result of lease reassessment	$ 18.5
Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on disposition of property, plant, and equipment	$ 45.8

Discontinued Operations - Sched

Discontinued Operations - Schedule of Future minimum Lease Payments for Construction Finance Liability (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Remainder of 2023	$ 4,186
2024	17,043
2025	17,521
2026	18,013
2027	18,519
Thereafter	302,424
Total future payments	377,706
Less: Interest	(239,490)
Total present value of minimum payments	138,216
Construction finance liability - current portion	(1,393)	$ (1,189)
Construction finance liability	136,823	$ 137,144
Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Remainder of 2023	1,347
2024	5,455
2025	5,619
2026	5,788
2027	5,961
Thereafter	18,427
Total future payments	42,597
Less: Interest	(15,983)
Total present value of minimum payments	26,614
Construction finance liability - current portion	(1,897)
Construction finance liability	$ 24,717

Variable Interest Entities - Ad

Variable Interest Entities - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Variable Interest Entity [Line Items]
Loss on impairment and disposal of long-lived assets, net	$ (1,209)		$ 54,639	$ 5,480	$ 76,155
Variable Interest Entities
Variable Interest Entity [Line Items]
Cash		$ 400				$ 800
Business combination consideration transferred equity interests issued and issuable	1,700	$ 1,700
Loss on deconsolidation of variable interest entity	10,000			10,000
Minority ownership interest received cash	1,800			$ 1,800
Loss on impairment and disposal of long-lived assets, net	$ 800
Minimum
Variable Interest Entity [Line Items]
Ownership interests (as a percent)				46%
Maximum
Variable Interest Entity [Line Items]
Ownership interests (as a percent)				95%

Variable Interest Entities - Su

Variable Interest Entities - Summary of Assets and Liabilities of Company's VIEs (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current Assets:
Accounts receivable, net	$ 6,886	$ 6,507
Inventories	229,897	276,505
Prepaid expenses and other current assets	43,733	62,278
Total current assets	486,669	593,543
Property and equipment, net	687,578	743,260
Right of use assets - operating, net	96,251	98,926
Right of use assets - finance, net	61,092	70,495
Intangible assets, net	934,560	984,797
Other assets	11,087	12,768
TOTAL ASSETS	2,775,191	3,400,405
Current Liabilities:
Accounts payable and accrued liabilities	86,443	82,023
Income tax payable	0	49,615
Deferred revenue	3,561	9,459
Operating lease liabilities - current portion	9,697	10,291
Finance lease liabilities - current portion	7,537	8,271
Total current liabilities	251,772	210,295
Notes payable, net	92,309	94,247
Operating lease liabilities	92,611	99,851
Finance lease liabilities	63,642	69,948
Deferred tax liabilities	205,441	224,903
Other long-term liabilities	86,439	26,279
TOTAL LIABILITIES	1,334,482	1,472,701
Variable Interest Entity, Primary Beneficiary
Current Assets:
Cash	7,335	7,349
Accounts receivable, net	1,386	597
Inventories	8,730	7,590
Prepaid expenses and other current assets	641	46
Total current assets	18,092	15,582
Property and equipment, net	28,248	25,994
Right of use assets - operating, net	2,781	0
Right of use assets - finance, net	278	224
Intangible assets, net	17,496	17,947
Other assets	147	344
TOTAL ASSETS	67,042	60,091
Current Liabilities:
Accounts payable and accrued liabilities	2,308	3,713
Income tax payable	2,538	1,615
Deferred revenue	2	6
Operating lease liabilities - current portion	44	0
Finance lease liabilities - current portion	59	41
Total current liabilities	4,951	5,375
Notes payable, net	982	1,200
Operating lease liabilities	2,961	0
Finance lease liabilities	227	185
Deferred tax liabilities	3,663	4,101
Other long-term liabilities	670	625
TOTAL LIABILITIES	$ 13,454	$ 11,486

Related Parties - Right of Use

Related Parties - Right of Use Assets and Lease Liabilities under ASC 842 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Operating
Right-of-use assets, net	$ 96,251	$ 98,926
Lease liabilities:
Lease liabilities - current portion	9,697	10,291
Lease liabilities	92,611	99,851
Total present value of minimum lease payments	102,308
Management
Operating
Right-of-use assets, net	736	820
Lease liabilities:
Lease liabilities - current portion	123	113
Lease liabilities	658	751
Total present value of minimum lease payments	$ 781	$ 864

Related Parties - Additional In

Related Parties - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Related Party Transactions [Abstract]
Related party, lease expense (less than)	$ 0.1	$ 0.1	$ 0.1	$ 0.2

Revenue Disaggregation - Schedu

Revenue Disaggregation - Schedule of Net Revenues Comprised (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 275,210	$ 295,353	$ 842,219	$ 919,753
Retail
Disaggregation of Revenue [Line Items]
Revenue	263,166	282,765	809,899	870,410
Wholesale, Licensing and Other
Disaggregation of Revenue [Line Items]
Revenue	$ 12,044	$ 12,588	$ 32,320	$ 49,343

Commitments And Contingencies -

Commitments And Contingencies - Additional Information (Details) $ in Millions	Sep. 30, 2023 USD ($) earnout	Dec. 31, 2022 USD ($)
Loss Contingencies [Line Items]
Number of potential earnouts | earnout	4
Settlement of previous litigation	$ 22.5
Estimates related to various sales tax	0.2
Contingent Liabilities
Loss Contingencies [Line Items]
Estimates related to various sales tax		$ 3
Pending Litigation | Contingent Liabilities
Loss Contingencies [Line Items]
Contingent liabilities	$ 3.6	$ 31.7

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) $ in Millions	Nov. 08, 2023 USD ($)
Subsequent Events | June and November Notes
Subsequent Event [Line Items]
Debt instrument face amount	$ 130